Thomas Jefferson University

Marilyn Huestis

TitleInstructor CHP
InstitutionThomas Jefferson University
DepartmentOffice of Research Admin - Thomas Jefferson University
Address1020 Locust Street
Philadelphia PA 19107
Phone4105442456
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    Z01DA000468     (HUESTIS, MARILYN A)
    NIH
    Neurobiology and Pharmacokinetics of Acute MDMA Administration
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Aks IR, Patel H, Pelham WE, Huestis MA, Wade NE. Cannabinoids in hair and their prospective association with mental and physical health outcomes in adolescents. Neurotoxicol Teratol. 2025 Mar-Apr; 108:107433. PMID: 39929394.
      Citations:    
    2. Sempio C, Campos-Palomino J, Klawitter J, Zhao W, Huestis MA, Christians U, Klawitter J. Quantification of 11 kratom alkaloids including mitragynine and its main metabolites in human plasma using LC-MS/MS. Anal Bioanal Chem. 2024 Dec 07. PMID: 39644381.
      Citations:    
    3. Huestis MA, Smith WB, Leonowens C, Blanchard R, Viaccoz A, Spargo E, Miner NB, Yazar-Klosinski B. MDMA pharmacokinetics: A population and physiologically based pharmacokinetics model-informed analysis. CPT Pharmacometrics Syst Pharmacol. 2024 Nov 26. PMID: 39592887.
      Citations:    
    4. Gameli PS, Huestis MA, Balloni A, Busard? FP, Carlier J. Metabolism and detection of designer benzodiazepines: a systematic review. Drug Metab Rev. 2024 Oct 14; 1-26. PMID: 39340261.
      Citations:    
    5. Torrens A, Mabou Tagne A, Tran A, Ahmed F, Huestis MA, Piomelli D. Comparative Pharmacokinetics of ?9-Tetrahydrocannabinol in Adolescent and Adult Female Mice. Cannabis Cannabinoid Res. 2024 Aug 20. PMID: 39162003.
      Citations:    
    6. Snozek CLH, Yee CI, Bryksin J, Dahal R, Gerson B, Gherasim C, Hauff KD, Heger N, Huestis MA, Johnson-Davis KL, Knezevic CE, Love SA, Melanson SEF, Noguez JH, Pikulski M, Roper S, Tyagi M, Warrington JS, Yang HS, Yang YK. Assessing knowledge gaps and educational needs in urine drug test interpretation among health care professionals. Am J Clin Pathol. 2024 Jul 26. PMID: 39066575.
      Citations:    
    7. Wallace AL, Huestis MA, Sullivan RM, Wade NE. Amygdala Volume and Depression Symptoms in Young Adolescents Who Use Cannabis. Behav Brain Res. 2024 Jul 13; 115150. PMID: 39009188.
      Citations:    
    8. Wickens CM, Wright M, Mann RE, Brands B, Di Ciano P, Stoduto G, Fares A, Matheson J, George TP, Rehm J, Shuper PA, Sproule B, Samohkvalov A, Huestis MA, Le Foll B. Corrigendum to "Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trial" [Progress in Neuropsychopharmacology & Biological Psychiatry 118 (2022) 110570]. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Jun 26; 111074. PMID: 38937224.
      Citations:    
    9. Arndt C, Huestis MA, Jarvis HC, Gray TR. Assessment of urine drug screen utility at autopsy to predict laboratory postmortem blood toxicology. J Forensic Sci. 2024 Jun 19. PMID: 38898613.
      Citations:    
    10. Sempio C, Jorge Campos-Palomino MS, Klawitter J, Amy Harrison MA, Peters EN, MacNair L, Haghdoost M, Bonn-Miller M, Babalonis S, Huestis MA, Christians U, Klawitter J. LC-MS/MS quantification of ?8-THC, ?9-THC, THCV ISOMERS and their main metabolites in human plasma. J Anal Toxicol. 2024 Jun 05. PMID: 38836589.
      Citations:    
    11. Henningfield JE, Grundmann O, Huestis MA, Smith KE. Kratom safety and toxicology in the public health context: research needs to better inform regulation. Front Pharmacol. 2024; 15:1403140. PMID: 38887550.
      Citations:    
    12. Bergh MS, Bogen IL, Grafinger KE, Huestis MA, ?iestad ?ML. Metabolite markers for three synthetic tryptamines N-ethyl-N-propyltryptamine, 4-hydroxy-N-ethyl-N-propyltryptamine, and 5-methoxy-N-ethyl-N-propyltryptamine. Drug Test Anal. 2024 Mar 09. PMID: 38459837.
      Citations:    
    13. Scherer JN, Vasconcelos M, Dalanhol CS, Govoni B, Dos Santos BP, Borges GR, de Gouveia GC, Viola PP, Carlson RLR, Martins AF, Costa JL, Huestis MA, Pechansky F. Reliability of roadside oral fluid testing devices for ?9 -tetrahydrocannabinol (?9 -THC) detection. Drug Test Anal. 2024 Mar 05. PMID: 38440942.
      Citations:    
    14. Balloni A, Tini A, Prospero E, Busard? FP, Huestis MA, Lo Faro AF. Exposure to Synthetic Psychoactive Substances: A Potential Cause for Increased Human Hepatotoxicity Markers. Clin Chem. 2024 Mar 01. PMID: 38427953.
      Citations:    
    15. Gjerde H, Huestis MA, Mulima G, Kajombo C, Sundet M, Pechansky F. Recommendations for effective collaboration and capacity building in epidemiological studies on the effect of alcohol and drug use on traffic safety in low- and middle-income countries. Traffic Inj Prev. 2024 Mar 01; 1-9. PMID: 38426896.
      Citations:    
    16. Huestis MA, Brett MA, Bothmer J, Atallah R. Human Mitragynine and 7-Hydroxymitragynine Pharmacokinetics after Single and Multiple Daily Doses of Oral Encapsulated Dried Kratom Leaf Powder. Molecules. 2024 Feb 23; 29(5). PMID: 38474495.
      Citations:    
    17. Rozanc J, Klumpers LE, Huestis MA, Tagen M. Tolerability of High-Dose Oral ?9-THC: Implications for Human Laboratory Study Design. Cannabis Cannabinoid Res. 2024 Feb 19. PMID: 38377580.
      Citations:    
    18. Godoi AB, Antunes NJ, Cunha KF, Martins AF, Huestis MA, Costa JL. Metabolic Stability and Metabolite Identification of N-Ethyl Pentedrone Using Rat, Mouse and Human Liver Microsomes. Pharmaceutics. 2024 Feb 09; 16(2). PMID: 38399311.
      Citations:    
    19. Wade NE, Wallace AL, Huestis MA, Lisdahl KM, Sullivan RM, Tapert SF. Cannabis use and neurocognitive performance at 13-14 Years-Old: Optimizing assessment with hair toxicology in the Adolescent brain cognitive development (ABCD) study. Addict Behav. 2024 Mar; 150:107930. PMID: 38091780.
      Citations:    
    20. Cliburn KD, Kemp PM, Huestis MA, Wagner JR, Payton M, Liu L, Liang Y, Maxwell LK. Time- and Temperature-Dependent Postmortem ?9-Tetrahydrocannabinol Concentration Changes in Rabbits following Controlled Inhaled Cannabis Administration. J Anal Toxicol. 2023 Sep 27. PMID: 37758448.
      Citations:    
    21. Boachie N, Gaudette E, Bazinet RP, Lin L, Tyndale RF, Mansouri E, Huestis MA, Tong J, Le Foll B, Kish SJ, George TP, Boileau I. Circulating Endocannabinoids and N-Acylethanolamines in Individuals with Cannabis Use Disorder-Preliminary Findings. Brain Sci. 2023 Sep 27; 13(10). PMID: 37891745.
      Citations:    
    22. Marcotte TD, Umlauf A, Grelotti DJ, Sones EG, Mastropietro KF, Suhandynata RT, Huestis MA, Grant I, Fitzgerald RL. Evaluation of Field Sobriety Tests for Identifying Drivers Under the Influence of Cannabis: A Randomized Clinical Trial. JAMA Psychiatry. 2023 Sep 01; 80(9):914-923. PMID: 37531115.
      Citations:    
    23. Hudzik TJ, Huestis MA, Rossi SS, Schumacher YO, Harcourt P, Budgett R, Stuart M, Tettey J, Mazzoni I, Rabin O, Danion A, Culler M, Handelsman D, Thevis M, Kinahan A. Cannabis and sport: A World Anti-Doping perspective. Addiction. 2023 11; 118(11):2040-2042. PMID: 37574590.
      Citations:    
    24. Fitzgerald RL, Umlauf A, Hubbard JA, Hoffman MA, Sobolesky PM, Ellis SE, Grelotti DJ, Suhandynata RT, Huestis MA, Grant I, Marcotte TD. Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests. Clin Chem. 2023 07 05; 69(7):724-733. PMID: 37228223.
      Citations:    
    25. Henningfield JE, Chawarski MC, Garcia-Romeu A, Grundmann O, Harun N, Hassan Z, McCurdy CR, McMahon LR, Sharma A, Shoaib M, Singh D, Smith KE, Swogger MT, Vicknasingam B, Walsh Z, Wang DW, Huestis MA. Kratom withdrawal: Discussions and conclusions of a scientific expert forum. Drug Alcohol Depend Rep. 2023 Jun; 7:100142. PMID: 37397437.
      Citations:    
    26. Lo Faro AF, Berardinelli D, Cassano T, Dendramis G, Montanari E, Montana A, Berretta P, Zaami S, Busard? FP, Huestis MA. New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic. Biology (Basel). 2023 Feb 08; 12(2). PMID: 36829550.
      Citations:    
    27. Kong KL, Lee JK, Shisler S, Thanos PK, Huestis MA, Hawk L, Eiden RD. Prenatal tobacco and cannabis co-exposure and offspring obesity development from birth to mid-childhood. Pediatr Obes. 2023 05; 18(5):e13010. PMID: 36734672.
      Citations:    
    28. Carlier J, Malaca S, Huestis MA, Tagliabracci A, Tini A, Busard? FP. Biomarkers of 4-hydroxy-N,N-methylpropyltryptamine (4-OH-MPT) intake identified from human hepatocyte incubations. Expert Opin Drug Metab Toxicol. 2022 Dec; 18(12):831-840. PMID: 36609205.
      Citations:    
    29. Wade NE, Sullivan RM, Tapert SF, Pelham WE, Huestis MA, Lisdahl KM, Haist F. Concordance between substance use self-report and hair analysis in community-based adolescents. Am J Drug Alcohol Abuse. 2023 01 02; 49(1):76-84. PMID: 36812240.
      Citations:    
    30. Torrens A, Ruiz CM, Martinez MX, Tagne AM, Roy P, Grimes D, Ahmed F, Lallai V, Inshishian V, Bautista M, Chen YC, Huestis MA, Das A, Fowler CD, Mahler SV, Piomelli D. Nasal accumulation and metabolism of ?9-tetrahydrocannabinol following aerosol ('vaping') administration in an adolescent rat model. Pharmacol Res. 2023 01; 187:106600. PMID: 36481259.
      Citations:    
    31. Poyatos L, Lo Faro AF, Berardinelli D, Sprega G, Malaca S, Pichini S, Huestis MA, Papaseit E, P?rez-Ma?? C, Busard? FP, Farr? M. Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans. Int J Mol Sci. 2022 Nov 23; 23(23). PMID: 36498963.
      Citations:    
    32. Di Trana A, Berardinelli D, Montanari E, Berretta P, Basile G, Huestis MA, Busard? FP. Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances. Int J Mol Sci. 2022 Nov 23; 23(23). PMID: 36498947.
      Citations:    
    33. Simon SG, Eiden RD, Molnar DS, Huestis MA, Riis JL. Associations between prenatal and postnatal substance exposure and salivary C-reactive protein in early childhood. Neurotoxicol Teratol. 2023 Jan-Feb; 95:107134. PMID: 36395973.
      Citations:    
    34. Ahmed F, Torrens A, Mahler SV, Ferlenghi F, Huestis MA, Piomelli D. A Sensitive Ultrahigh-Performance Liquid Chromatography/Tandem Mass Spectrometry Method for the Simultaneous Analysis of Phytocannabinoids and Endocannabinoids in Plasma and Brain. Cannabis Cannabinoid Res. 2022 Nov 11. PMID: 36367975.
      Citations:    
    35. Henningfield JE, Rodricks JV, Magnuson AM, Huestis MA. Respiratory effects of oral mitragynine and oxycodone in a rodent model. Psychopharmacology (Berl). 2022 Dec; 239(12):3793-3804. PMID: 36308562.
      Citations:    
    36. Pigliasco F, Malaca S, Lo Faro AF, Tini A, Cangemi G, Cafaro A, Barco S, Riva A, Pisati A, Amadori E, Striano P, Tagliabracci A, Huestis MA, Busard? FP. Cannabidiol, ?9-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients. Front Pharmacol. 2022; 13:1038754. PMID: 36353497.
      Citations:    
    37. La Maida N, Di Giorgi A, Pichini S, Busard? FP, Huestis MA. Recent challenges and trends in forensic analysis: ?9-THC isomers pharmacology, toxicology and analysis. J Pharm Biomed Anal. 2022 Oct 25; 220:114987. PMID: 35985136.
      Citations:    
    38. Malaca S, Huestis MA, Lattanzio L, Marsella LT, Tagliabracci A, Carlier J, Busard? FP. Human Hepatocyte 4-Acetoxy-N,N-Diisopropyltryptamine Metabolite Profiling by Reversed-Phase Liquid Chromatography Coupled with High-Resolution Tandem Mass Spectrometry. Metabolites. 2022 Jul 29; 12(8). PMID: 36005577.
      Citations:    
    39. Mohr ALA, Logan BK, Fogarty MF, Krotulski AJ, Papsun DM, Kacinko SL, Huestis MA, Ropero-Miller JD. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review. J Anal Toxicol. 2022 Jul 14; 46(6):e116-e185. PMID: 35445267.
      Citations:    
    40. Mareck U, Fussh?ller G, Schertel T, Petring S, Huestis MA, Thevis M. Risk of unintentional antidoping rule violations by consumption of hemp products. Drug Test Anal. 2022 May 28. PMID: 35633098.
      Citations:    
    41. Wickens CM, Wright M, Mann RE, Brands B, Di Ciano P, Stoduto G, Fares A, Matheson J, George TP, Rehm J, Shuper PA, Sproule B, Samohkvalov A, Huestis MA, Le Foll B. Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trial. Prog Neuropsychopharmacol Biol Psychiatry. 2022 08 30; 118:110570. PMID: 35551928.
      Citations:    
    42. Gilman JM, Schmitt WA, Potter K, Kendzior B, Pachas GN, Hickey S, Makary M, Huestis MA, Evins AE. Correction to: Identification of ?9-tetrahydrocannabinol (THC) impairment using functional brain imaging. Neuropsychopharmacology. 2022 May; 47(6):1282. PMID: 35228659.
      Citations:    
    43. Sempio C, Huestis MA, Kaplan B, Klawitter J, Christians U, Henthorn TK. Urinary clearance of 11-nor-9-carboxy-?9 -tetrahydrocannabinol: A detailed pharmacokinetic analysis. Drug Test Anal. 2022 Aug; 14(8):1368-1376. PMID: 35332698.
      Citations:    
    44. Wade NE, Tapert SF, Lisdahl KM, Huestis MA, Haist F. Substance use onset in high-risk 9-13?year-olds in the ABCD study. Neurotoxicol Teratol. 2022 May-Jun; 91:107090. PMID: 35341934.
      Citations:    
    45. Marcotte TD, Umlauf A, Grelotti DJ, Sones EG, Sobolesky PM, Smith BE, Hoffman MA, Hubbard JA, Severson J, Huestis MA, Grant I, Fitzgerald RL. Driving Performance and Cannabis Users' Perception of Safety: A Randomized Clinical Trial. JAMA Psychiatry. 2022 Mar 01; 79(3):201-209. PMID: 35080588.
      Citations:    
    46. Henningfield JE, Wang DW, Huestis MA. Kratom Abuse Potential 2021: An Updated Eight Factor Analysis. Front Pharmacol. 2021; 12:775073. PMID: 35197848.
      Citations:    
    47. Gilman JM, Schmitt WA, Potter K, Kendzior B, Pachas GN, Hickey S, Makary M, Huestis MA, Evins AE. Identification of ?9-tetrahydrocannabinol (THC) impairment using functional brain imaging. Neuropsychopharmacology. 2022 03; 47(4):944-952. PMID: 34999737.
      Citations:    
    48. Tuv SS, Bergh MS, Andersen JM, Steinsland S, Vindenes V, Baumann MH, Huestis MA, Bogen IL. Comparative Neuropharmacology and Pharmacokinetics of Methamphetamine and Its Thiophene Analog Methiopropamine in Rodents. Int J Mol Sci. 2021 Nov 05; 22(21). PMID: 34769427.
      Citations:    
    49. Cliburn KD, Huestis MA, Wagner JR, Kemp PM. Cannabinoid distribution in fatally-injured pilots' postmortem fluids and tissues. Forensic Sci Int. 2021 Dec; 329:111075. PMID: 34749280.
      Citations:    
    50. Hoffman MA, Hubbard JA, Sobolesky PM, Smith BE, Suhandynata RT, Sanford S, Sones EG, Ellis S, Umlauf A, Huestis MA, Grelotti DJ, Grant I, Marcotte TD, Fitzgerald RL. Blood and Oral Fluid Cannabinoid Profiles of Frequent and Occasional Cannabis Smokers. J Anal Toxicol. 2021 Sep 17; 45(8):851-862. PMID: 34173005.
      Citations:    
    51. Hubbard JA, Hoffman MA, Ellis SE, Sobolesky PM, Smith BE, Suhandynata RT, Sones EG, Sanford SK, Umlauf A, Huestis MA, Grelotti DJ, Grant I, Marcotte TD, Fitzgerald RL. Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath. J Anal Toxicol. 2021 Sep 17; 45(8):820-828. PMID: 34185831.
      Citations:    
    52. Rodrigues TB, Morais DR, Gianvecchio VAP, Aquino EM, Cunha RL, Huestis MA, Costa JL. Development and Validation of a Method for Quantification of 28 Psychotropic Drugs in Postmortem Blood Samples by Modified Micro-QuEChERS and LC-MS-MS. J Anal Toxicol. 2021 Aug 14; 45(7):644-656. PMID: 32991709.
      Citations:    
    53. da Cunha KF, Oliveira KD, Cardoso MS, Arantes ACF, Coser PHP, Lima LN, Maluf ACS, Comis MAC, Huestis MA, Costa JL. Prevalence of new psychoactive substances (NPS) in Brazil based on oral fluid analysis of samples collected at electronic music festivals and parties. Drug Alcohol Depend. 2021 10 01; 227:108962. PMID: 34461412.
      Citations:    
    54. Sempio C, Bidwell LC, Hutchison K, Huestis MA, Klawitter J, Christians U, Henthorn TK. Using Population Pharmacokinetic Modeling to Estimate Exposure to ?9-Tetrahydrocannabinol in an Observational Study of Cannabis Smokers in Colorado. Ther Drug Monit. 2021 08 01; 43(4):536-545. PMID: 33656464.
      Citations:    
    55. Lisdahl KM, Tapert S, Sher KJ, Gonzalez R, Nixon SJ, Feldstein Ewing SW, Conway KP, Wallace A, Sullivan R, Hatcher K, Kaiver C, Thompson W, Reuter C, Bartsch H, Wade NE, Jacobus J, Albaugh MD, Allgaier N, Anokhin AP, Bagot K, Baker FC, Banich MT, Barch DM, Baskin-Sommers A, Breslin FJ, Brown SA, Calhoun V, Casey BJ, Chaarani B, Chang L, Clark DB, Cloak C, Constable RT, Cottler LB, Dagher RK, Dapretto M, Dick A, Do EK, Dosenbach NUF, Dowling GJ, Fair DA, Florsheim P, Foxe JJ, Freedman EG, Friedman NP, Garavan HP, Gee DG, Glantz MD, Glaser P, Gonzalez MR, Gray KM, Grant S, Haist F, Hawes S, Heeringa SG, Hermosillo R, Herting MM, Hettema JM, Hewitt JK, Heyser C, Hoffman EA, Howlett KD, Huber RS, Huestis MA, Hyde LW, Iacono WG, Isaiah A, Ivanova MY, James RS, Jernigan TL, Karcher NR, Kuperman JM, Laird AR, Larson CL, LeBlanc KH, Lopez MF, Luciana M, Luna B, Maes HH, Marshall AT, Mason MJ, McGlade E, Morris AS, Mulford C, Nagel BJ, Neigh G, Palmer CE, Paulus MP, Pecheva D, Prouty D, Potter A, Puttler LI, Rajapakse N, Ross JM, Sanchez M, Schirda C, Schulenberg J, Sheth C, Shilling PD, Sowell ER, Speer N, Squeglia L, Sripada C, Steinberg J, Sutherland MT, Tomko R, Uban K, Vrieze S, Weiss SRB, Wing D, Yurgelun-Todd DA, Zucker RA, Heitzeg MM. Substance use patterns in 9-10 year olds: Baseline findings from the adolescent brain cognitive development (ABCD) study. Drug Alcohol Depend. 2021 10 01; 227:108946. PMID: 34392051.
      Citations:    
    56. Wickens CM, Mann RE, Brands B, Stoduto G, Matheson J, Sayer G, Burston J, Pan JF, Di Ciano P, George TP, Rehm J, Kenney C, Soule D, Huestis MA, Le Foll B. Influence of personality on acute smoked cannabis effects on simulated driving. Exp Clin Psychopharmacol. 2022 Oct; 30(5):547-559. PMID: 34291988.
      Citations:    
    57. D'Orazio AL, Mohr ALA, Chan-Hosokawa A, Harper C, Huestis MA, Limoges JF, Miles AK, Scarneo CE, Kerrigan S, Liddicoat LJ, Scott KS, Logan BK. Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities-2021 Update. J Anal Toxicol. 2021 Jul 10; 45(6):529-536. PMID: 34086916.
      Citations:    
    58. Wade NE, Baca R, Courtney KE, McCabe CJ, Infante MA, Huestis MA, Jacobus J. Preliminary Evidence for Cannabis and Nicotine Urinary Metabolites as Predictors of Verbal Memory Performance and Learning Among Young Adults. J Int Neuropsychol Soc. 2021 07; 27(6):546-558. PMID: 34261558.
      Citations:    
    59. Cliburn KD, Huestis MA, Wagner JR, Kemp PM. Identification and quantification of cannabinoids in postmortem fluids and tissues by liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2021 Aug 30; 1652:462345. PMID: 34198104.
      Citations:    
    60. Brunetti P, Giorgetti R, Tagliabracci A, Huestis MA, Busard? FP. Designer Benzodiazepines: A Review of Toxicology and Public Health Risks. Pharmaceuticals (Basel). 2021 Jun 11; 14(6). PMID: 34208284.
      Citations:    
    61. Chaarani B, Hahn S, Allgaier N, Adise S, Owens MM, Juliano AC, Yuan DK, Loso H, Ivanciu A, Albaugh MD, Dumas J, Mackey S, Laurent J, Ivanova M, Hagler DJ, Cornejo MD, Hatton S, Agrawal A, Aguinaldo L, Ahonen L, Aklin W, Anokhin AP, Arroyo J, Avenevoli S, Babcock D, Bagot K, Baker FC, Banich MT, Barch DM, Bartsch H, Baskin-Sommers A, Bjork JM, Blachman-Demner D, Bloch M, Bogdan R, Bookheimer SY, Breslin F, Brown S, Calabro FJ, Calhoun V, Casey BJ, Chang L, Clark DB, Cloak C, Constable RT, Constable K, Corley R, Cottler LB, Coxe S, Dagher RK, Dale AM, Dapretto M, Delcarmen-Wiggins R, Dick AS, Do EK, Dosenbach NUF, Dowling GJ, Edwards S, Ernst TM, Fair DA, Fan CC, Feczko E, Feldstein-Ewing SW, Florsheim P, Foxe JJ, Freedman EG, Friedman NP, Friedman-Hill S, Fuemmeler BF, Galvan A, Gee DG, Giedd J, Glantz M, Glaser P, Godino J, Gonzalez M, Gonzalez R, Grant S, Gray KM, Haist F, Harms MP, Hawes S, Heath AC, Heeringa S, Heitzeg MM, Hermosillo R, Herting MM, Hettema JM, Hewitt JK, Heyser C, Hoffman E, Howlett K, Huber RS, Huestis MA, Hyde LW, Iacono WG, Infante MA, Irfanoglu O, Isaiah A, Iyengar S, Jacobus J, James R, Jean-Francois B, Jernigan T, Karcher NR, Kaufman A, Kelley B, Kit B, Ksinan A, Kuperman J, Laird AR, Larson C, LeBlanc K, Lessov-Schlagger C, Lever N, Lewis DA, Lisdahl K, Little AR, Lopez M, Luciana M, Luna B, Madden PA, Maes HH, Makowski C, Marshall AT, Mason MJ, Matochik J, McCandliss BD, McGlade E, Montoya I, Morgan G, Morris A, Mulford C, Murray P, Nagel BJ, Neale MC, Neigh G, Nencka A, Noronha A, Nixon SJ, Palmer CE, Pariyadath V, Paulus MP, Pelham WE, Pfefferbaum D, Pierpaoli C, Prescot A, Prouty D, Puttler LI, Rajapaske N, Rapuano KM, Reeves G, Renshaw PF, Riedel MC, Rojas P, de la Rosa M, Rosenberg MD, Ross MJ, Sanchez M, Schirda C, Schloesser D, Schulenberg J, Sher KJ, Sheth C, Shilling PD, Simmons WK, Sowell ER, Speer N, Spittel M, Squeglia LM, Sripada C, Steinberg J, Striley C, Sutherland MT, Tanabe J, Tapert SF, Thompson W, Tomko RL, Uban KA, Vrieze S, Wade NE, Watts R, Weiss S, Wiens BA, Williams OD, Wilbur A, Wing D, Wolff-Hughes D, Yang R, Yurgelun-Todd DA, Zucker RA, Potter A, Garavan HP. Baseline brain function in the preadolescents of the ABCD Study. Nat Neurosci. 2021 08; 24(8):1176-1186. PMID: 34099922.
      Citations:    
    62. Wright M, Wickens CM, Di Ciano P, Sproule B, Fares A, Matheson J, Mann RE, Rehm J, Shuper PA, George TP, Huestis MA, Stoduto G, Le Foll B, Brands B. Sex differences in the acute pharmacological and subjective effects of smoked cannabis combined with alcohol in young adults. Psychol Addict Behav. 2021 Aug; 35(5):536-552. PMID: 34081489.
      Citations:    
    63. Preuss UW, Huestis MA, Schneider M, Hermann D, Lutz B, Hasan A, Kambeitz J, Wong JWM, Hoch E. Cannabis Use and Car Crashes: A Review. Front Psychiatry. 2021; 12:643315. PMID: 34122176.
      Citations:    
    64. Herting MM, Uban KA, Gonzalez MR, Baker FC, Kan EC, Thompson WK, Granger DA, Albaugh MD, Anokhin AP, Bagot KS, Banich MT, Barch DM, Baskin-Sommers A, Breslin FJ, Casey BJ, Chaarani B, Chang L, Clark DB, Cloak CC, Constable RT, Cottler LB, Dagher RK, Dapretto M, Dick AS, Dosenbach N, Dowling GJ, Dumas JA, Edwards S, Ernst T, Fair DA, Feldstein-Ewing SW, Freedman EG, Fuemmeler BF, Garavan H, Gee DG, Giedd JN, Glaser PEA, Goldstone A, Gray KM, Hawes SW, Heath AC, Heitzeg MM, Hewitt JK, Heyser CJ, Hoffman EA, Huber RS, Huestis MA, Hyde LW, Infante MA, Ivanova MY, Jacobus J, Jernigan TL, Karcher NR, Laird AR, LeBlanc KH, Lisdahl K, Luciana M, Luna B, Maes HH, Marshall AT, Mason MJ, McGlade EC, Morris AS, Nagel BJ, Neigh GN, Palmer CE, Paulus MP, Potter AS, Puttler LI, Rajapakse N, Rapuano K, Reeves G, Renshaw PF, Schirda C, Sher KJ, Sheth C, Shilling PD, Squeglia LM, Sutherland MT, Tapert SF, Tomko RL, Yurgelun-Todd D, Wade NE, Weiss SRB, Zucker RA, Sowell ER. Correspondence Between Perceived Pubertal Development and Hormone Levels in 9-10 Year-Olds From the Adolescent Brain Cognitive Development Study. Front Endocrinol (Lausanne). 2020; 11:549928. PMID: 33679599.
      Citations:    
    65. Fares A, Wickens CM, Mann RE, Di Ciano P, Wright M, Matheson J, Hasan OSM, Rehm J, George TP, Samokhvalov AV, Shuper PA, Huestis MA, Stoduto G, Brown T, Stefan C, Rubin-Kahana DS, Le Foll B, Brands B. Combined effect of alcohol and cannabis on simulated driving. Psychopharmacology (Berl). 2022 May; 239(5):1263-1277. PMID: 33544195.
      Citations:    
    66. La Maida N, Di Trana A, Giorgetti R, Tagliabracci A, Busard? FP, Huestis MA. A Review of Synthetic Cathinone-Related Fatalities From 2017 to 2020. Ther Drug Monit. 2021 02 01; 43(1):52-68. PMID: 32881779.
      Citations:    
    67. Carlier J, Diao X, Giorgetti R, Busard? FP, Huestis MA. Pyrrolidinyl Synthetic Cathinones a-PHP and 4F-a-PVP Metabolite Profiling Using Human Hepatocyte Incubations. Int J Mol Sci. 2020 Dec 28; 22(1). PMID: 33379373.
      Citations:    
    68. Mareck U, Fussh?ller G, Geyer H, Huestis MA, Scheiff AB, Thevis M. Preliminary data on the potential for unintentional antidoping rule violations by permitted cannabidiol (CBD) use. Drug Test Anal. 2021 Mar; 13(3):539-549. PMID: 33125823.
      Citations:    
    69. Malaca S, Lo Faro AF, Tamborra A, Pichini S, Busard? FP, Huestis MA. Toxicology and Analysis of Psychoactive Tryptamines. Int J Mol Sci. 2020 Dec 04; 21(23). PMID: 33291798.
      Citations:    
    70. Hahn B, Harvey AN, Concheiro-Guisan M, Huestis MA, Ross TJ, Stein EA. Nicotinic receptor modulation of the default mode network. Psychopharmacology (Berl). 2021 Feb; 238(2):589-597. PMID: 33216167.
      Citations:    
    71. Chu EK, Smith LM, Derauf C, Newman E, Neal CR, Arria AM, Huestis MA, DellaGrotta SA, Roberts MB, Dansereau LM, Lester BM. Behavior Problems During Early Childhood in Children With Prenatal Methamphetamine Exposure. Pediatrics. 2020 12; 146(6). PMID: 33172920.
      Citations:    
    72. Sezer Y, Jannuzzi AT, Huestis MA, Alpertunga B. In vitro assessment of the cytotoxic, genotoxic and oxidative stress effects of the synthetic cannabinoid JWH-018 in human SH-SY5Y neuronal cells. Toxicol Res (Camb). 2020 Dec; 9(6):734-740. PMID: 33447358.
      Citations:    
    73. Sholler DJ, Huestis MA, Amendolara B, Vandrey R, Cooper ZD. Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids. Pharmacol Biochem Behav. 2020 12; 199:173059. PMID: 33086126.
      Citations:    
    74. da Cunha KF, Oliveira KD, Huestis MA, Costa JL. Screening of 104 New Psychoactive Substances (NPS) and Other Drugs of Abuse in Oral Fluid by LC-MS-MS. J Anal Toxicol. 2020 Oct 12; 44(7):697-707. PMID: 32685960.
      Citations:    
    75. Sofalvi S, Lavins ES, Kaspar CK, Michel HM, Mitchell-Mata CL, Huestis MA, Apollonio LG. Development and Validation of an LC-MS-MS Method for the Detection of 40 Benzodiazepines and Three Z-Drugs in Blood and Urine by Solid-Phase Extraction. J Anal Toxicol. 2020 Oct 12; 44(7):708-717. PMID: 32808043.
      Citations:    
    76. Huestis MA, Sempio C, Newmeyer MN, Andersson M, Barnes AJ, Abulseoud OA, Blount BC, Schroeder J, Smith ML. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users. J Anal Toxicol. 2020 Oct 12; 44(7):651-660. PMID: 32369162.
      Citations:    
    77. Miller RE, Brown TL, Lee S, Tibrewal I, Gaffney GG, Milavetz G, Hartman RL, Gorelick DA, Compton R, Huestis MA. Impact of cannabis and low alcohol concentration on divided attention tasks during driving. Traffic Inj Prev. 2020 10 12; 21(sup1):S123-S129. PMID: 33035082.
      Citations:    
    78. Ruiz CM, Torrens A, Castillo E, Perrone CR, Cevallos J, Inshishian VC, Harder EV, Justeson DN, Huestis MA, Swarup V, Piomelli D, Mahler SV. Pharmacokinetic, behavioral, and brain activity effects of ?9-tetrahydrocannabinol in adolescent male and female rats. Neuropsychopharmacology. 2021 04; 46(5):959-969. PMID: 32927465.
      Citations:    
    79. Ashley DL, De Jes?s VR, Abulseoud OA, Huestis MA, Milan DF, Blount BC. Urinary Acrylonitrile Metabolite Concentrations Before and after Smoked, Vaporized, and Oral Cannabis in Frequent and Occasional Cannabis Users. Int J Environ Res Public Health. 2020 09 04; 17(18). PMID: 32899602.
      Citations:    
    80. Hampson AJ, Schroeder JR, Ellefsen KN, Yammine L, Epstein DH, Preston KL, Huestis MA, Verrico CD. Subtherapeutic Acetazolamide Doses as a Noninvasive Method for Assessing Medication Adherence. Clin Pharmacol Ther. 2020 12; 108(6):1203-1212. PMID: 32496573.
      Citations:    
    81. Karschner EL, Swortwood-Gates MJ, Huestis MA. Identifying and Quantifying Cannabinoids in Biological Matrices in the Medical and Legal Cannabis Era. Clin Chem. 2020 07 01; 66(7):888-914. PMID: 32628766.
      Citations:    
    82. Schuetze P, Molnar D, Eiden RD, Shisler S, Zhao J, Colder CR, Huestis MA. The effect of prenatal adversity on externalizing behaviors at 24 months of age in a high-risk sample: Maternal sensitivity as a moderator. Infant Ment Health J. 2020 07; 41(4):530-542. PMID: 32594565.
      Citations:    
    83. Withey SL, Bergman J, Huestis MA, George SR, Madras BK. THC and CBD blood and brain concentrations following daily administration to adolescent primates. Drug Alcohol Depend. 2020 Aug 01; 213:108129. PMID: 32593153.
      Citations:    
    84. da Cunha KF, Rodrigues LC, Huestis MA, Costa JL. Erratum to "Miniaturized extraction method for analysis of synthetic opioids in urine by microextraction with packed sorbent and liquid chromatography-tandem mass spectrometry" [J. Chromatogr. A 1624 (2020) 461241]. J Chromatogr A. 2020 08 16; 1625:461321. PMID: 32713462.
      Citations:    
    85. Eiden RD, Shisler S, Granger DA, Schuetze P, Colangelo J, Huestis MA. Prenatal Tobacco and Cannabis Exposure: Associations with Cortisol Reactivity in Early School Age Children. Int J Behav Med. 2020 Jun; 27(3):343-356. PMID: 32291618.
      Citations:    
    86. da Cunha KF, Rodrigues LC, Huestis MA, Costa JL. Miniaturized extraction method for analysis of synthetic opioids in urine by microextraction with packed sorbent and liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2020 Aug 02; 1624:461241. PMID: 32540079.
      Citations:    
    87. Matheson J, Mann RE, Sproule B, Huestis MA, Wickens CM, Stoduto G, George TP, Rehm J, Le Foll B, Brands B. Acute and residual mood and cognitive performance of young adults following smoked cannabis. Pharmacol Biochem Behav. 2020 07; 194:172937. PMID: 32360692.
      Citations:    
    88. Torrens A, Vozella V, Huff H, McNeil B, Ahmed F, Ghidini A, Mahler SV, Huestis MA, Das A, Piomelli D. Comparative Pharmacokinetics of ?9-Tetrahydrocannabinol in Adolescent and Adult Male Mice. J Pharmacol Exp Ther. 2020 07; 374(1):151-160. PMID: 32345621.
      Citations:    
    89. Hubbard JA, Smith BE, Sobolesky PM, Kim S, Hoffman MA, Stone J, Huestis MA, Grelotti DJ, Grant I, Marcotte TD, Fitzgerald RL. Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to detect cannabinoids in whole blood and breath. Clin Chem Lab Med. 2020 04 28; 58(5):673-681. PMID: 31527291.
      Citations:    
    90. Pacifici R, Pichini S, Pellegrini M, Rotolo MC, Giorgetti R, Tagliabracci A, Busard? FP, Huestis MA. THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis". Clin Chem Lab Med. 2020 04 28; 58(5):682-689. PMID: 30956228.
      Citations:    
    91. Loflin MJE, Kiluk BD, Huestis MA, Aklin WM, Budney AJ, Carroll KM, D'Souza DC, Dworkin RH, Gray KM, Hasin DS, Lee DC, Le Foll B, Levin FR, Lile JA, Mason BJ, McRae-Clark AL, Montoya I, Peters EN, Ramey T, Turk DC, Vandrey R, Weiss RD, Strain EC. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. Drug Alcohol Depend. 2020 07 01; 212:107993. PMID: 32360455.
      Citations:    
    92. Stroud LR, Papandonatos GD, Jao NC, Vergara-Lopez C, Huestis MA, Salisbury AL. Prenatal tobacco and marijuana co-use: Sex-specific influences on infant cortisol stress response. Neurotoxicol Teratol. 2020 May - Jun; 79:106882. PMID: 32289444.
      Citations:    
    93. Carlier J, Huestis MA, Zaami S, Pichini S, Busard? FP. Monitoring Perinatal Exposure to Cannabis and Synthetic Cannabinoids. Ther Drug Monit. 2020 04; 42(2):194-204. PMID: 32195988.
      Citations:    
    94. Carlier J, La Maida N, Di Trana A, Huestis MA, Pichini S, Busard? FP. Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids. Ther Drug Monit. 2020 04; 42(2):205-221. PMID: 31809406.
      Citations:    
    95. Di Trana A, La Maida N, Tittarelli R, Huestis MA, Pichini S, Busard? FP, Carlier J. Monitoring Prenatal Exposure to Buprenorphine and Methadone. Ther Drug Monit. 2020 04; 42(2):181-193. PMID: 31425444.
      Citations:    
    96. Farokhnia M, McDiarmid GR, Newmeyer MN, Munjal V, Abulseoud OA, Huestis MA, Leggio L. Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study. Transl Psychiatry. 2020 02 19; 10(1):71. PMID: 32075958.
      Citations:    
    97. Sempio C, Huestis MA, Mikulich-Gilbertson SK, Klawitter J, Christians U, Henthorn TK. Population pharmacokinetic modeling of plasma ?9-tetrahydrocannabinol and an active and inactive metabolite following controlled smoked cannabis administration. Br J Clin Pharmacol. 2020 03; 86(3):611-619. PMID: 31747464.
      Citations:    
    98. Tomko RL, Gray KM, Huestis MA, Squeglia LM, Baker NL, McClure EA. Measuring Within-Individual Cannabis Reduction in Clinical Trials: A Review of the Methodological Challenges. Curr Addict Rep. 2019 Dec; 6(4):429-436. PMID: 32133273.
      Citations:    
    99. Brands B, Mann RE, Wickens CM, Sproule B, Stoduto G, Sayer GS, Burston J, Pan JF, Matheson J, Stefan C, George TP, Huestis MA, Rehm J, Le Foll B. Acute and residual effects of smoked cannabis: Impact on driving speed and lateral control, heart rate, and self-reported drug effects. Drug Alcohol Depend. 2019 12 01; 205:107641. PMID: 31678833.
      Citations:    
    100. Bonn-Miller MO, Pollack CV, Casarett D, Dart R, ElSohly M, Good L, Guzmán M, Hanuš L, Hill KP, Huestis MA, Marsh E, Sisley S, Skinner N, Spahr J, Vandrey R, Viscusi E, Ware MA, Abrams D. Priority Considerations for Medicinal Cannabis-Related Research. Cannabis Cannabinoid Res. 2019; 4(3):139-157. PMID: 31579832.
      Citations:    
    101. Desrosiers NA, Huestis MA. Oral Fluid Drug Testing: Analytical Approaches, Issues and Interpretation of Results. J Anal Toxicol. 2019 Jul 24; 43(6):415-443. PMID: 31263897.
      Citations:    
    102. Baggott MJ, Garrison KJ, Coyle JR, Galloway GP, Barnes AJ, Huestis MA, Mendelson JE. Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers. J Psychoactive Drugs. 2019 Apr-Jun; 51(2):108-117. PMID: 30967099.
      Citations:    
    103. Huestis MA, Blount BC, Milan DF, Newmeyer MN, Schroeder J, Smith ML. Correlation of creatinine- and specific gravity-normalized free and glucuronidated urine cannabinoid concentrations following smoked, vaporized, and oral cannabis in frequent and occasional cannabis users. Drug Test Anal. 2019 Jul; 11(7):968-975. PMID: 30756523.
      Citations:    
    104. Schuetze P, Zhao J, Eiden RD, Shisler S, Huestis MA. Prenatal exposure to tobacco and marijuana and child autonomic regulation and reactivity: An analysis of indirect pathways via maternal psychopathology and parenting. Dev Psychobiol. 2019 11; 61(7):1022-1034. PMID: 30868568.
      Citations:    
    105. Diao X, Huestis MA. New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites. Front Chem. 2019; 7:109. PMID: 30886845.
      Citations:    
    106. Huestis MA, Solimini R, Pichini S, Pacifici R, Carlier J, Busard? FP. Cannabidiol Adverse Effects and Toxicity. Curr Neuropharmacol. 2019; 17(10):974-989. PMID: 31161980.
      Citations:    
    107. Carlier J, Wohlfarth A, Salmeron BD, Scheidweiler KB, Huestis MA, Baumann MH. Pharmacodynamic Effects, Pharmacokinetics, and Metabolism of the Synthetic Cannabinoid AM-2201 in Male Rats. J Pharmacol Exp Ther. 2018 12; 367(3):543-550. PMID: 30266766.
      Citations:    
    108. Stroud LR, Papandonatos GD, McCallum M, Kehoe T, Salisbury AL, Huestis MA. Prenatal tobacco and marijuana co-use: Impact on newborn neurobehavior. Neurotoxicol Teratol. 2018 Nov - Dec; 70:28-39. PMID: 30266574.
      Citations:    
    109. Semick SA, Collado-Torres L, Markunas CA, Shin JH, Deep-Soboslay A, Tao R, Huestis MA, Bierut LJ, Maher BS, Johnson EO, Hyde TM, Weinberger DR, Hancock DB, Kleinman JE, Jaffe AE. Developmental effects of maternal smoking during pregnancy on the human frontal cortex transcriptome. Mol Psychiatry. 2020 12; 25(12):3267-3277. PMID: 30131587.
      Citations:    
    110. Godleski SA, Shisler S, Eiden RD, Huestis MA. Co-use of tobacco and marijuana during pregnancy: Pathways to externalizing behavior problems in early childhood. Neurotoxicol Teratol. 2018 Sep - Oct; 69:39-48. PMID: 30081085.
      Citations:    
    111. Hirvonen J, Zanotti-Fregonara P, Gorelick DA, Lyoo CH, Rallis-Frutos D, Morse C, Zoghbi SS, Pike VW, Volkow ND, Huestis MA, Innis RB. Decreased Cannabinoid CB1 Receptors in Male Tobacco Smokers Examined With Positron Emission Tomography. Biol Psychiatry. 2018 11 15; 84(10):715-721. PMID: 30121138.
      Citations:    
    112. Massey SH, Mroczek DK, Reiss D, Miller ES, Jakubowski JA, Graham EK, Shisler SM, McCallum M, Huestis MA, Ganiban JM, Shaw DS, Leve LD, Eiden RD, Stroud LR, Neiderhiser JM. Additive drug-specific and sex-specific risks associated with co-use of marijuana and tobacco during pregnancy: Evidence from 3 recent developmental cohorts (2003-2015). Neurotoxicol Teratol. 2018 Jul - Aug; 68:97-106. PMID: 29886244.
      Citations:    
    113. Carlier J, Diao X, Huestis MA. Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection. J Pharm Biomed Anal. 2018 Aug 05; 157:27-35. PMID: 29754040.
      Citations:    
    114. Smith MJ, Alden EC, Herrold AA, Roberts A, Stern D, Jones J, Barnes A, O'Connor KP, Huestis MA, Breiter HC. Recent Self-Reported Cannabis Use Is Associated With the Biometrics of Delta-9-Tetrahydrocannabinol. J Stud Alcohol Drugs. 2018 05; 79(3):441-446. PMID: 29885152.
      Citations:    
    115. Eiden RD, Schuetze P, Shisler S, Huestis MA. Prenatal exposure to tobacco and cannabis: Effects on autonomic and emotion regulation. Neurotoxicol Teratol. 2018 Jul - Aug; 68:47-56. PMID: 29727701.
      Citations:    
    116. Concheiro M, Huestis MA. Drug exposure during pregnancy: analytical methods and toxicological findings. Bioanalysis. 2018 Apr 01; 10(8):587-606. PMID: 29561633.
      Citations:    
    117. Logan BK, D'Orazio AL, Mohr ALA, Limoges JF, Miles AK, Scarneo CE, Kerrigan S, Liddicoat LJ, Scott KS, Huestis MA. Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities-2017 Update. J Anal Toxicol. 2018 Mar 01; 42(2):63-68. PMID: 29186455.
      Citations:    
    118. Huestis MA, Smith ML. Cannabinoid Markers in Biological Fluids and Tissues: Revealing Intake. Trends Mol Med. 2018 02; 24(2):156-172. PMID: 29398403.
      Citations:    
    119. Trigo JM, Soliman A, Quilty LC, Fischer B, Rehm J, Selby P, Barnes AJ, Huestis MA, George TP, Streiner DL, Staios G, Le Foll B. Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial. PLoS One. 2018; 13(1):e0190768. PMID: 29385147.
      Citations:    
    120. Jannetto PJ, Bratanow NC, Clark WA, Hamill-Ruth RJ, Hammett-Stabler CA, Huestis MA, Kassed CA, McMillin GA, Melanson SE, Langman LJ. Executive Summary: American Association of Clinical Chemistry Laboratory Medicine Practice Guideline-Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients. J Appl Lab Med. 2018 Jan 01; 2(4):489-526. PMID: 33636890.
      Citations:    
    121. Lucendo-Villarin B, Filis P, Swortwood MJ, Huestis MA, Meseguer-Ripolles J, Cameron K, Iredale JP, O'Shaughnessy PJ, Fowler PA, Hay DC. Erratum to: Modelling foetal exposure to maternal smoking using hepatoblasts from pluripotent stem cells. Arch Toxicol. 2017 11; 91(11):3645. PMID: 28980015.
      Citations:    
    122. Jacobus J, Squeglia LM, Escobar S, McKenna BM, Hernandez MM, Bagot KS, Taylor CT, Huestis MA. Changes in marijuana use symptoms and emotional functioning over 28-days of monitored abstinence in adolescent marijuana users. Psychopharmacology (Berl). 2017 Dec; 234(23-24):3431-3442. PMID: 28900686.
      Citations:    
    123. Logan BK, Mohr ALA, Friscia M, Krotulski AJ, Papsun DM, Kacinko SL, Ropero-Miller JD, Huestis MA. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review. J Anal Toxicol. 2017 Sep 01; 41(7):573-610. PMID: 28459969.
      Citations:    
    124. Bouhlal S, Ellefsen KN, Sheskier MB, Singley E, Pirard S, Gorelick DA, Huestis MA, Leggio L. Acute effects of intravenous cocaine administration on serum concentrations of ghrelin, amylin, glucagon-like peptide-1, insulin, leptin and peptide YY and relationships with cardiorespiratory and subjective responses. Drug Alcohol Depend. 2017 11 01; 180:68-75. PMID: 28881319.
      Citations:    
    125. Diao X, Carlier J, Zhu M, Huestis MA. Human Hepatocyte Metabolism of Novel Synthetic Cannabinoids MN-18 and Its 5-Fluoro Analog 5F-MN-18. Clin Chem. 2017 Nov; 63(11):1753-1763. PMID: 28821542.
      Citations:    
    126. Sempio C, Scheidweiler KB, Barnes AJ, Huestis MA. Optimization of recombinant ?-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry. Drug Test Anal. 2018 Mar; 10(3):518-529. PMID: 28815938.
      Citations:    
    127. Lucendo-Villarin B, Filis P, Swortwood MJ, Huestis MA, Meseguer-Ripolles J, Cameron K, Iredale JP, O'Shaughnessy PJ, Fowler PA, Hay DC. Erratum to: Modelling foetal exposure to maternal smoking using hepatoblasts from pluripotent stem cells. Arch Toxicol. 2017 Jul 21. PMID: 28733887.
      Citations:    
    128. Carlier J, Diao X, Wohlfarth A, Scheidweiler K, Huestis MA. In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid. Curr Neuropharmacol. 2017 Jul; 15(5):682-691. PMID: 29403341.
      Citations:    
    129. Molnar DS, Rancourt D, Schlauch R, Wen X, Huestis MA, Eiden RD. Tobacco Exposure and Conditional Weight-for-Length Gain by 2 Years of Age. J Pediatr Psychol. 2017 07 01; 42(6):679-688. PMID: 28169405.
      Citations:    
    130. Huestis MA, Brandt SD, Rana S, Auw?rter V, Baumann MH. Impact of Novel Psychoactive Substances on Clinical and Forensic Toxicology and Global Public Health. Clin Chem. 2017 10; 63(10):1564-1569. PMID: 28667187.
      Citations:    
    131. Lucendo-Villarin B, Filis P, Swortwood MJ, Huestis MA, Meseguer-Ripolles J, Cameron K, Iredale JP, O'Shaughnessy PJ, Fowler PA, Hay DC. Modelling foetal exposure to maternal smoking using hepatoblasts from pluripotent stem cells. Arch Toxicol. 2017 Nov; 91(11):3633-3643. PMID: 28510779.
      Citations:    
    132. Shisler S, Eiden RD, Molnar DS, Schuetze P, Huestis M, Homish G. Smoking in Pregnancy and Fetal Growth: The Case for More Intensive Assessment. Nicotine Tob Res. 2017 May 01; 19(5):525-531. PMID: 28403474.
      Citations:    
    133. Abulseoud OA, Zuccoli ML, Zhang L, Barnes A, Huestis MA, Lin DT. The acute effect of cannabis on plasma, liver and brain ammonia dynamics, a translational study. Eur Neuropsychopharmacol. 2017 07; 27(7):679-690. PMID: 28456476.
      Citations:    
    134. Schuetze P, Eiden RD, Colder CR, Huestis MA, Leonard KE. Prenatal Risk and Infant Regulation: Indirect Pathways via Fetal Growth and Maternal Prenatal Stress and Anger. Child Dev. 2018 03; 89(2):e123-e137. PMID: 28383108.
      Citations:    
    135. Newmeyer MN, Swortwood MJ, Abulseoud OA, Huestis MA. Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration. Drug Alcohol Depend. 2017 06 01; 175:67-76. PMID: 28407543.
      Citations:    
    136. Carlier J, Diao X, Scheidweiler KB, Huestis MA. Distinguishing Intake of New Synthetic Cannabinoids ADB-PINACA and 5F-ADB-PINACA with Human Hepatocyte Metabolites and High-Resolution Mass Spectrometry. Clin Chem. 2017 05; 63(5):1008-1021. PMID: 28302730.
      Citations:    
    137. Lee MR, Scheidweiler KB, Diao XX, Akhlaghi F, Cummins A, Huestis MA, Leggio L, Averbeck BB. Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay. Mol Psychiatry. 2018 01; 23(1):115-122. PMID: 28289281.
      Citations:    
    138. Newmeyer MN, Swortwood MJ, Andersson M, Abulseoud OA, Scheidweiler KB, Huestis MA. Cannabis Edibles: Blood and Oral Fluid Cannabinoid Pharmacokinetics and Evaluation of Oral Fluid Screening Devices for Predicting ?9-Tetrahydrocannabinol in Blood and Oral Fluid following Cannabis Brownie Administration. Clin Chem. 2017 03; 63(3):647-662. PMID: 28188235.
      Citations:    
    139. Huestis MA, Tyndale RF. Designer Drugs 2.0. Clin Pharmacol Ther. 2017 Feb; 101(2):152-157. PMID: 28084644.
      Citations:    
    140. Newmeyer MN, Swortwood MJ, Taylor ME, Abulseoud OA, Woodward TH, Huestis MA. Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration. J Appl Toxicol. 2017 08; 37(8):922-932. PMID: 28138971.
      Citations:    
    141. Carlier J, Diao X, Sempio C, Huestis MA. Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes. AAPS J. 2017 03; 19(2):568-577. PMID: 28070717.
      Citations:    
    142. Baumann MH, Bukhari MO, Lehner KR, Anizan S, Rice KC, Concheiro M, Huestis MA. Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs. Curr Top Behav Neurosci. 2017; 32:93-117. PMID: 27830575.
      Citations:    
    143. Diao X, Huestis MA. Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites. Clin Pharmacol Ther. 2017 Feb; 101(2):239-253. PMID: 27727455.
      Citations:    
    144. Jacobus J, Castro N, Squeglia LM, Meloy MJ, Brumback T, Huestis MA, Tapert SF. Reprint of "Adolescent cortical thickness pre- and post marijuana and alcohol initiation". Neurotoxicol Teratol. 2016 Nov - Dec; 58:78-87. PMID: 27856361.
      Citations:    
    145. Carlier J, Diao X, Wohlfarth A, Scheidweiler K, Huestis MA. In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid. Curr Neuropharmacol. 2016 Nov 08. PMID: 27829332.
      Citations:    
    146. Swortwood MJ, Newmeyer MN, Andersson M, Abulseoud OA, Scheidweiler KB, Huestis MA. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration. Drug Test Anal. 2017 Jun; 9(6):905-915. PMID: 27647820.
      Citations:    
    147. Newmeyer MN, Swortwood MJ, Barnes AJ, Abulseoud OA, Scheidweiler KB, Huestis MA. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake. Clin Chem. 2016 Dec; 62(12):1579-1592. PMID: 27899456.
      Citations:    
    148. Wiegand SL, Swortwood MJ, Huestis MA, Thorp J, Jones HE, Vora NL. Naloxone and Metabolites Quantification in Cord Blood of Prenatally Exposed Newborns and Correlations with Maternal Concentrations. AJP Rep. 2016 Oct; 6(4):e385-e390. PMID: 27896019.
      Citations:    
    149. Jansson LM, Spencer N, McConnell K, Velez M, Tuten M, Harrow CA, Jones HE, Swortwood MJ, Barnes AJ, Scheidweiler KB, Huestis MA. Maternal Buprenorphine Maintenance and Lactation. J Hum Lact. 2016 Nov; 32(4):675-681. PMID: 27563013.
      Citations:    
    150. Jacobus J, Castro N, Squeglia LM, Meloy MJ, Brumback T, Huestis MA, Tapert SF. Adolescent cortical thickness pre- and post marijuana and alcohol initiation. Neurotoxicol Teratol. 2016 Sep - Oct; 57:20-29. PMID: 27687470.
      Citations:    
    151. Elmore JS, Dillon-Carter O, Partilla JS, Ellefsen KN, Concheiro M, Suzuki M, Rice KC, Huestis MA, Baumann MH. Pharmacokinetic Profiles and Pharmacodynamic Effects for Methylone and Its Metabolites in Rats. Neuropsychopharmacology. 2017 02; 42(3):649-660. PMID: 27658484.
      Citations:    
    152. Scheidweiler KB, Andersson M, Swortwood MJ, Sempio C, Huestis MA. Long-term stability of cannabinoids in oral fluid after controlled cannabis administration. Drug Test Anal. 2017 Jan; 9(1):143-147. PMID: 27539096.
      Citations:    
    153. Wilsey BL, Deutsch R, Samara E, Marcotte TD, Barnes AJ, Huestis MA, Le D. A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis. J Pain Res. 2016; 9:587-98. PMID: 27621666.
      Citations:    
    154. Shisler S, Eiden RD, Molnar DS, Schuetze P, Coles CD, Huestis M, Colder CR. Effects of fetal tobacco exposure on focused attention in infancy. Infant Behav Dev. 2016 Nov; 45(Pt A):1-10. PMID: 27543942.
      Citations:    
    155. Wohlfarth A, Roman M, Andersson M, Kugelberg FC, Diao X, Carlier J, Eriksson C, Wu X, Konradsson P, Josefsson M, Huestis MA, Kronstrand R. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry. Drug Test Anal. 2017 May; 9(5):680-698. PMID: 27448631.
      Citations:    
    156. Feasel MG, Wohlfarth A, Nilles JM, Pang S, Kristovich RL, Huestis MA. Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass Spectrometry. AAPS J. 2016 11; 18(6):1489-1499. PMID: 27495118.
      Citations:    
    157. Godleski SA, Eiden RD, Schuetze P, Colder CR, Huestis MA. Tobacco exposure and maternal psychopathology: Impact on toddler problem behavior. Neurotoxicol Teratol. 2016 Sep - Oct; 57:87-94. PMID: 27498223.
      Citations:    
    158. Andersson M, Scheidweiler KB, Sempio C, Barnes AJ, Huestis MA. Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips. Anal Bioanal Chem. 2016 Sep; 408(23):6461-71. PMID: 27422645.
      Citations:    
    159. Diao X, Carlier J, Zhu M, Pang S, Kronstrand R, Scheidweiler KB, Huestis MA. In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201). Forensic Toxicol. 2017 Jan; 35(1):20-32. PMID: 28286577.
      Citations:    
    160. Trigo JM, Soliman A, Staios G, Quilty L, Fischer B, George TP, Rehm J, Selby P, Barnes AJ, Huestis MA, Le Foll B. Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series. J Addict Med. 2016 Jul-Aug; 10(4):274-9. PMID: 27261670.
      Citations:    
    161. Baggott MJ, Garrison KJ, Coyle JR, Galloway GP, Barnes AJ, Huestis MA, Mendelson JE. MDMA Impairs Response to Water Intake in Healthy Volunteers. Adv Pharmacol Sci. 2016; 2016:2175896. PMID: 27403159.
      Citations:    
    162. Eriksen GS, Andersen JM, Boix F, Bergh MS, Vindenes V, Rice KC, Huestis MA, M?rland J. Comparison of (+)- and (-)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice. J Pharmacol Exp Ther. 2016 08; 358(2):209-15. PMID: 27278234.
      Citations:    
    163. Ellefsen KN, Concheiro M, Huestis MA. Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases. Drug Metab Rev. 2016 05; 48(2):237-65. PMID: 27249313.
      Citations:    
    164. Swortwood MJ, Ellefsen KN, Wohlfarth A, Diao X, Concheiro-Guisan M, Kronstrand R, Huestis MA. First metabolic profile of PV8, a novel synthetic cathinone, in human hepatocytes and urine by high-resolution mass spectrometry. Anal Bioanal Chem. 2016 Jul; 408(18):4845-56. PMID: 27185540.
      Citations:    
    165. Scheidweiler KB, Newmeyer MN, Barnes AJ, Huestis MA. Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2016 Jul 01; 1453:34-42. PMID: 27236483.
      Citations:    
    166. Carlier J, Scheidweiler KB, Wohlfarth A, Salmeron BD, Baumann MH, Huestis MA. Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2016 Jun 17; 1451:97-106. PMID: 27208987.
      Citations:    
    167. Andersson M, Diao X, Wohlfarth A, Scheidweiler KB, Huestis MA. Metabolic profiling of new synthetic cannabinoids AMB and 5F-AMB by human hepatocyte and liver microsome incubations and high-resolution mass spectrometry. Rapid Commun Mass Spectrom. 2016 Apr 30; 30(8):1067-78. PMID: 27003044.
      Citations:    
    168. Boileau I, Mansouri E, Williams B, Le Foll B, Rusjan P, Mizrahi R, Tyndale RF, Huestis MA, Payer DE, Wilson AA, Houle S, Kish SJ, Tong J. Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB. Biol Psychiatry. 2016 11 01; 80(9):691-701. PMID: 27345297.
      Citations:    
    169. Hartman RL, Richman JE, Hayes CE, Huestis MA. Drug Recognition Expert (DRE) examination characteristics of cannabis impairment. Accid Anal Prev. 2016 Jul; 92:219-29. PMID: 27107471.
      Citations:    
    170. Ellefsen KN, Concheiro M, Pirard S, Gorelick DA, Huestis MA. Pharmacodynamic effects and relationships to plasma and oral fluid pharmacokinetics after intravenous cocaine administration. Drug Alcohol Depend. 2016 Jun 01; 163:116-25. PMID: 27114201.
      Citations:    
    171. Swortwood MJ, Scheidweiler KB, Barnes AJ, Jansson LM, Huestis MA. Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2016 May 13; 1446:70-7. PMID: 27083254.
      Citations:    
    172. Diao X, Scheidweiler KB, Wohlfarth A, Zhu M, Pang S, Huestis MA. Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytes. Forensic Toxicol. 2016; 34:256-267. PMID: 27547265.
      Citations:    
    173. Ellefsen KN, Concheiro M, Pirard S, Gorelick DA, Huestis MA. Cocaine and benzoylecgonine oral fluid on-site screening and confirmation. Drug Test Anal. 2016 Mar-Apr; 8(3-4):296-303. PMID: 26968560.
      Citations:    
    174. Trigo JM, Lagzdins D, Rehm J, Selby P, Gamaleddin I, Fischer B, Barnes AJ, Huestis MA, Le Foll B. Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings. Drug Alcohol Depend. 2016 Apr 01; 161:298-306. PMID: 26925704.
      Citations:    
    175. Hartman RL, Brown TL, Milavetz G, Spurgin A, Pierce RS, Gorelick DA, Gaffney G, Huestis MA. Cannabis effects on driving longitudinal control with and without alcohol. J Appl Toxicol. 2016 11; 36(11):1418-29. PMID: 26889769.
      Citations:    
    176. Hartman RL, Brown TL, Milavetz G, Spurgin A, Gorelick DA, Gaffney GR, Huestis MA. Effect of Blood Collection Time on Measured ?9-Tetrahydrocannabinol Concentrations: Implications for Driving Interpretation and Drug Policy. Clin Chem. 2016 Feb; 62(2):367-77. PMID: 26823611.
      Citations:    
    177. And?s HT, Enger A, ?iestad ?M, Vindenes V, Christophersen AS, Huestis MA, ?iestad EL. Extended Detection of Amphetamine and Methamphetamine in Oral Fluid. Ther Drug Monit. 2016 Feb; 38(1):114-9. PMID: 26402425.
      Citations:    
    178. Diao X, Scheidweiler KB, Wohlfarth A, Pang S, Kronstrand R, Huestis MA. In Vitro and In Vivo Human Metabolism of Synthetic Cannabinoids FDU-PB-22 and FUB-PB-22. AAPS J. 2016 Mar; 18(2):455-64. PMID: 26810398.
      Citations:    
    179. Ellefsen KN, Concheiro M, Pirard S, Gorelick DA, Huestis MA. Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration. Forensic Sci Int. 2016 Mar; 260:95-101. PMID: 26851651.
      Citations:    
    180. Eze N, Smith LM, LaGasse LL, Derauf C, Newman E, Arria A, Huestis MA, Della Grotta SA, Dansereau LM, Neal C, Lester BM. School-Aged Outcomes following Prenatal Methamphetamine Exposure: 7.5-Year Follow-Up from the Infant Development, Environment, and Lifestyle Study. J Pediatr. 2016 Mar; 170:34-8.e1. PMID: 26781836.
      Citations:    
    181. Stroud LR, Papandonatos GD, Salisbury AL, Phipps MG, Huestis MA, Niaura R, Padbury JF, Marsit CJ, Lester BM. Epigenetic Regulation of Placental NR3C1: Mechanism Underlying Prenatal Programming of Infant Neurobehavior by Maternal Smoking? Child Dev. 2016 Jan-Feb; 87(1):49-60. PMID: 26822442.
      Citations:    
    182. Vaupel DB, Schindler CW, Chefer S, Belcher AM, Ahmet I, Scheidweiler KB, Huestis MA, Stein EA. Delayed emergence of methamphetamine's enhanced cardiovascular effects in nonhuman primates during protracted methamphetamine abstinence. Drug Alcohol Depend. 2016 Feb 01; 159:181-9. PMID: 26775284.
      Citations:    
    183. Swortwood MJ, Carlier J, Ellefsen KN, Wohlfarth A, Diao X, Concheiro-Guisan M, Kronstrand R, Huestis MA. In vitro, in vivo and in silico metabolic profiling of a-pyrrolidinopentiothiophenone, a novel thiophene stimulant. Bioanalysis. 2016; 8(1):65-82. PMID: 26648097.
      Citations:    
    184. Battal D, Barnes AJ, Castaneto MS, Martin TM, Klette KL, Huestis MA. Urine Mescaline Screening With a Biochip Array Immunoassay and Quantification by Gas Chromatography-Mass Spectrometry. Ther Drug Monit. 2015 Dec; 37(6):805-11. PMID: 25992796.
      Citations:    
    185. Diao X, Wohlfarth A, Pang S, Scheidweiler KB, Huestis MA. High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes. Clin Chem. 2016 Jan; 62(1):157-69. PMID: 26430074.
      Citations:    
    186. Lee D, Bergamaschi MM, Milman G, Barnes AJ, Queiroz RH, Vandrey R, Huestis MA. Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users. J Anal Toxicol. 2015 Oct; 39(8):580-7. PMID: 26378131.
      Citations:    
    187. Barnes AJ, Spinelli E, Young S, Martin TM, Kleete KL, Huestis MA. Validation of an ELISA Synthetic Cannabinoids Urine Assay. Ther Drug Monit. 2015 Oct; 37(5):661-9. PMID: 25706046.
      Citations:    
    188. Marin SJ, Doyle K, Chang A, Concheiro-Guisan M, Huestis MA, Johnson-Davis KL. One Hundred False-Positive Amphetamine Specimens Characterized by Liquid Chromatography Time-of-Flight Mass Spectrometry. J Anal Toxicol. 2016 Jan-Feb; 40(1):37-42. PMID: 26342055.
      Citations:    
    189. Wohlfarth A, Scheidweiler KB, Pang S, Zhu M, Castaneto M, Kronstrand R, Huestis MA. Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation. Drug Test Anal. 2016 Aug; 8(8):779-91. PMID: 26331297.
      Citations:    
    190. Huestis MA. Cannabis-impaired driving: a public health and safety concern. Clin Chem. 2015 Oct; 61(10):1223-5. PMID: 26283691.
      Citations:    
    191. Huestis MA. Deterring driving under the influence of cannabis. Addiction. 2015 Nov; 110(11):1697-8. PMID: 26264558.
      Citations:    
    192. Hartman RL, Brown TL, Milavetz G, Spurgin A, Gorelick DA, Gaffney G, Huestis MA. Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships. Drug Test Anal. 2016 Jul; 8(7):690-701. PMID: 26257143.
      Citations:    
    193. Ellefsen KN, Wohlfarth A, Swortwood MJ, Diao X, Concheiro M, Huestis MA. 4-Methoxy-a-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry. Forensic Toxicol. 2016; 34:61-75. PMID: 26793277.
      Citations:    
    194. Himes SK, Wu JW, Jacobson DL, Tassiopoulos K, Hazra R, Kacanek D, Van Dyke RB, Rich KC, Siberry GK, Huestis MA. Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected Children. Pediatr Infect Dis J. 2015 Aug; 34(8):851-7. PMID: 25961889.
      Citations:    
    195. Smith LM, Diaz S, LaGasse LL, Wouldes T, Derauf C, Newman E, Arria A, Huestis MA, Haning W, Strauss A, Della Grotta S, Dansereau LM, Neal C, Lester BM. Developmental and behavioral consequences of prenatal methamphetamine exposure: A review of the Infant Development, Environment, and Lifestyle (IDEAL) study. Neurotoxicol Teratol. 2015 Sep-Oct; 51:35-44. PMID: 26212684.
      Citations:    
    196. Hartman RL, Brown TL, Milavetz G, Spurgin A, Pierce RS, Gorelick DA, Gaffney G, Huestis MA. Cannabis effects on driving lateral control with and without alcohol. Drug Alcohol Depend. 2015 Sep 01; 154:25-37. PMID: 26144593.
      Citations:    
    197. Karschner EL, Swortwood MJ, Hirvonen J, Goodwin RS, Bosker WM, Ramaekers JG, Huestis MA. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance. Drug Test Anal. 2016 Jul; 8(7):682-9. PMID: 26097154.
      Citations:    
    198. Himes SK, Huo Y, Siberry GK, Williams PL, Rice ML, Sirois PA, Frederick T, Hazra R, Huestis MA. Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir Exposure. J Acquir Immune Defic Syndr. 2015 Jun 01; 69(2):178-86. PMID: 26009830.
      Citations:    
    199. Hartman RL, Brown TL, Milavetz G, Spurgin A, Gorelick DA, Gaffney G, Huestis MA. Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol. Clin Chem. 2015 Jun; 61(6):850-69. PMID: 26019183.
      Citations:    
    200. Tanner JA, Novalen M, Jatlow P, Huestis MA, Murphy SE, Kaprio J, Kankaanp?? A, Galanti L, Stefan C, George TP, Benowitz NL, Lerman C, Tyndale RF. Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1239-46. PMID: 26014804.
      Citations:    
    201. Himes SK, Tassiopoulos K, Yogev R, Huestis MA. Antiretroviral Drugs in Meconium: Detection for Different Gestational Periods of Exposure. J Pediatr. 2015 Aug; 167(2):305-11.e3. PMID: 26001315.
      Citations:    
    202. Manini AF, Yiannoulos G, Bergamaschi MM, Hernandez S, Olmedo R, Barnes AJ, Winkel G, Sinha R, Jutras-Aswad D, Huestis MA, Hurd YL. Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans. J Addict Med. 2015 May-Jun; 9(3):204-10. PMID: 25748562.
      Citations:    
    203. Castaneto MS, Barnes AJ, Concheiro M, Klette KL, Martin TA, Huestis MA. Biochip array technology immunoassay performance and quantitative confirmation of designer piperazines for urine workplace drug testing. Anal Bioanal Chem. 2015 Jun; 407(16):4639-48. PMID: 25903022.
      Citations:    
    204. Castaneto MS, Wohlfarth A, Desrosiers NA, Hartman RL, Gorelick DA, Huestis MA. Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices. Drug Metab Rev. 2015 May; 47(2):124-74. PMID: 25853390.
      Citations:    
    205. Concheiro M, Castaneto M, Kronstrand R, Huestis MA. Simultaneous determination of 40 novel psychoactive stimulants in urine by liquid chromatography-high resolution mass spectrometry and library matching. J Chromatogr A. 2015 Jun 05; 1397:32-42. PMID: 25931378.
      Citations:    
    206. Newmeyer MN, Concheiro M, da Costa JL, Flegel R, Gorelick DA, Huestis MA. Oral fluid with three modes of collection and plasma methamphetamine and amphetamine enantiomer concentrations after controlled intranasal l-methamphetamine administration. Drug Test Anal. 2015 Oct; 7(10):877-83. PMID: 25786659.
      Citations:    
    207. Kwako LE, Spagnolo PA, Schwandt ML, Thorsell A, George DT, Momenan R, Rio DE, Huestis M, Anizan S, Concheiro M, Sinha R, Heilig M. The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study. Neuropsychopharmacology. 2015 Mar 13; 40(5):1053-63. PMID: 25409596.
      Citations:    
    208. Desrosiers NA, Ramaekers JG, Chauchard E, Gorelick DA, Huestis MA. Smoked cannabis' psychomotor and neurocognitive effects in occasional and frequent smokers. J Anal Toxicol. 2015 May; 39(4):251-61. PMID: 25745105.
      Citations:    
    209. Wohlfarth A, Castaneto MS, Zhu M, Pang S, Scheidweiler KB, Kronstrand R, Huestis MA. Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA. AAPS J. 2015 May; 17(3):660-77. PMID: 25721194.
      Citations:    
    210. Schuetze P, Lessard J, Colder CR, Maiorana N, Shisler S, Eiden RD, Huestis MA, Henrie J. Physiological reactivity during object manipulation among cigarette-exposed infants at 9 months of age. Neurotoxicol Teratol. 2015 Mar-Apr; 48:64-8. PMID: 25681531.
      Citations:    
    211. Eiden RD, Molnar DS, Granger DA, Colder CR, Schuetze P, Huestis MA. Prenatal tobacco exposure and infant stress reactivity: role of child sex and maternal behavior. Dev Psychobiol. 2015 Mar; 57(2):212-25. PMID: 25650169.
      Citations:    
    212. Wohlfarth A, Scheidweiler KB, Castaneto M, Gandhi AS, Desrosiers NA, Klette KL, Martin TM, Huestis MA. Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens. Clin Chem Lab Med. 2015 Feb; 53(3):423-34. PMID: 25263309.
      Citations:    
    213. Himes SK, Dukes KA, Tripp T, Petersen JM, Raffo C, Burd L, Odendaal H, Elliott AJ, Hereld D, Signore C, Willinger M, Huestis MA. Clinical sensitivity and specificity of meconium fatty acid ethyl ester, ethyl glucuronide, and ethyl sulfate for detecting maternal drinking during pregnancy. Clin Chem. 2015 Mar; 61(3):523-32. PMID: 25595440.
      Citations:    
    214. Ellefsen KN, da Costa JL, Concheiro M, Anizan S, Barnes AJ, Pirard S, Gorelick DA, Huestis MA. Cocaine and metabolite concentrations in DBS and venous blood after controlled intravenous cocaine administration. Bioanalysis. 2015; 7(16):2041-56. PMID: 26327184.
      Citations:    
    215. Kuwabara H, Heishman SJ, Brasic JR, Contoreggi C, Cascella N, Mackowick KM, Taylor R, Rousset O, Willis W, Huestis MA, Concheiro M, Wand G, Wong DF, Volkow ND. Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers. PLoS One. 2014; 9(12):e113694. PMID: 25493427.
      Citations:    
    216. Anizan S, Concheiro M, Lehner KR, Bukhari MO, Suzuki M, Rice KC, Baumann MH, Huestis MA. Linear pharmacokinetics of 3,4-methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effects. Addict Biol. 2016 Mar; 21(2):339-47. PMID: 25475011.
      Citations:    
    217. Huestis MA. Commentary. Clin Chem. 2014 Dec; 60(12):1484-5. PMID: 25432994.
      Citations:    
    218. Desrosiers NA, Scheidweiler KB, Huestis MA. Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry. Drug Test Anal. 2015 Aug; 7(8):684-94. PMID: 25428610.
      Citations:    
    219. Concheiro M, Newmeyer MN, da Costa JL, Flegel R, Gorelick DA, Huestis MA. Morphine and codeine in oral fluid after controlled poppy seed administration. Drug Test Anal. 2015 Jul; 7(7):586-91. PMID: 25345619.
      Citations:    
    220. Smith ML, Nichols DC, Underwood P, Fuller Z, Moser MA, Flegel R, Gorelick DA, Newmeyer MN, Concheiro M, Huestis MA. Methamphetamine and amphetamine isomer concentrations in human urine following controlled Vicks VapoInhaler administration. J Anal Toxicol. 2014 Oct; 38(8):524-7. PMID: 25217541.
      Citations:    
    221. Abar B, LaGasse LL, Wouldes T, Derauf C, Newman E, Shah R, Smith LM, Arria AM, Huestis MA, DellaGrotta S, Dansereau LM, Wilcox T, Neal CR, Lester BM. Cross-national comparison of prenatal methamphetamine exposure on infant and early child physical growth: a natural experiment. Prev Sci. 2014 Oct; 15(5):767-76. PMID: 23943149.
      Citations:    
    222. Hartman RL, Huestis MA. Re: "trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999-2010". Am J Epidemiol. 2014 Oct 15; 180(8):862-3. PMID: 25245042.
      Citations:    
    223. Castaneto MS, Scheidweiler KB, Gandhi A, Wohlfarth A, Klette KL, Martin TM, Huestis MA. Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens. Drug Test Anal. 2015 Jun; 7(6):483-93. PMID: 25231213.
      Citations:    
    224. Scheidweiler KB, Jarvis MJ, Huestis MA. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry. Anal Bioanal Chem. 2015 Jan; 407(3):883-97. PMID: 25224637.
      Citations:    
    225. Lee D, Vandrey R, Mendu DR, Murray JA, Barnes AJ, Huestis MA. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. Drug Test Anal. 2015 Jun; 7(6):494-501. PMID: 25220020.
      Citations:    
    226. Spinelli E, Barnes AJ, Young S, Castaneto MS, Martin TM, Klette KL, Huestis MA. Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids. Drug Test Anal. 2015 Jun; 7(6):467-74. PMID: 25167963.
      Citations:    
    227. Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend. 2014 Nov 01; 144:12-41. PMID: 25220897.
      Citations:    
    228. Ellefsen KN, Concheiro M, Beck O, Gorelick DA, Pirard S, Huestis MA. Quantification of cocaine and metabolites in exhaled breath by liquid chromatography-high-resolution mass spectrometry following controlled administration of intravenous cocaine. Anal Bioanal Chem. 2014 Oct; 406(25):6213-23. PMID: 25129634.
      Citations:    
    229. Himes SK, LaGasse LL, Derauf C, Newman E, Smith LM, Arria AM, Della Grotta SA, Dansereau LM, Abar B, Neal CR, Lester BM, Huestis MA. Risk of neurobehavioral disinhibition in prenatal methamphetamine-exposed young children with positive hair toxicology results. Ther Drug Monit. 2014 Aug; 36(4):535-43. PMID: 24518561.
      Citations:    
    230. Himes SK, Huestis MA. In reply. Clin Chem. 2014 Sep; 60(9):1236-7. PMID: 25037935.
      Citations:    
    231. Newmeyer MN, Concheiro M, Huestis MA. Rapid quantitative chiral amphetamines liquid chromatography-tandem mass spectrometry: method in plasma and oral fluid with a cost-effective chiral derivatizing reagent. J Chromatogr A. 2014 Sep 05; 1358:68-74. PMID: 25065924.
      Citations:    
    232. Anizan S, Bergamaschi MM, Barnes AJ, Milman G, Desrosiers N, Lee D, Gorelick DA, Huestis MA. Impact of oral fluid collection device on cannabinoid stability following smoked cannabis. Drug Test Anal. 2015 Feb; 7(2):114-20. PMID: 24995604.
      Citations:    
    233. Gandhi AS, Zhu M, Pang S, Wohlfarth A, Scheidweiler KB, Huestis MA. Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS. Bioanalysis. 2014 Jun; 6(11):1471-85. PMID: 25046048.
      Citations:    
    234. Stroud LR, Papandonatos GD, Rodriguez D, McCallum M, Salisbury AL, Phipps MG, Lester B, Huestis MA, Niaura R, Padbury JF, Marsit CJ. Maternal smoking during pregnancy and infant stress response: test of a prenatal programming hypothesis. Psychoneuroendocrinology. 2014 Oct; 48:29-40. PMID: 24999830.
      Citations:    
    235. Desrosiers NA, Milman G, Mendu DR, Lee D, Barnes AJ, Gorelick DA, Huestis MA. Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices. Anal Bioanal Chem. 2014 Jul; 406(17):4117-28. PMID: 24828976.
      Citations:    
    236. Gandhi AS, Wohlfarth A, Zhu M, Pang S, Castaneto M, Scheidweiler KB, Huestis MA. High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes. Drug Test Anal. 2015 Mar; 7(3):187-98. PMID: 24827428.
      Citations:    
    237. Smith ML, Nichols DC, Underwood P, Fuller Z, Moser MA, LoDico C, Gorelick DA, Newmeyer MN, Concheiro M, Huestis MA. Morphine and codeine concentrations in human urine following controlled poppy seeds administration of known opiate content. Forensic Sci Int. 2014 Aug; 241:87-90. PMID: 24887324.
      Citations:    
    238. Wohlfarth A, Pang S, Zhu M, Gandhi AS, Scheidweiler KB, Huestis MA. Metabolism of RCS-8, a synthetic cannabinoid with cyclohexyl structure, in human hepatocytes by high-resolution MS. Bioanalysis. 2014 May; 6(9):1187-200. PMID: 24946920.
      Citations:    
    239. Lee D, Schroeder JR, Karschner EL, Goodwin RS, Hirvonen J, Gorelick DA, Huestis MA. Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment. Am J Addict. 2014 May-Jun; 23(3):234-42. PMID: 24724880.
      Citations:    
    240. Barnes AJ, Young S, Spinelli E, Martin TM, Klette KL, Huestis MA. Evaluation of a homogenous enzyme immunoassay for the detection of synthetic cannabinoids in urine. Forensic Sci Int. 2014 Aug; 241:27-34. PMID: 24845968.
      Citations:    
    241. Anizan S, Ellefsen K, Concheiro M, Suzuki M, Rice KC, Baumann MH, Huestis MA. 3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography-high resolution mass spectrometry. Anal Chim Acta. 2014 May 27; 827:54-63. PMID: 24832995.
      Citations:    
    242. Milman G, Bergamaschi MM, Lee D, Mendu DR, Barnes AJ, Vandrey R, Huestis MA. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence. Ther Drug Monit. 2014 Apr; 36(2):218-24. PMID: 24067260.
      Citations:    
    243. Barnes AJ, Scheidweiler KB, Huestis MA. Quantification of 11-nor-9-carboxy-d9-tetrahydrocannabinol in human oral fluid by gas chromatography-tandem mass spectrometry. Ther Drug Monit. 2014 Apr; 36(2):225-33. PMID: 24622724.
      Citations:    
    244. Ellefsen KN, Anizan S, Castaneto MS, Desrosiers NA, Martin TM, Klette KL, Huestis MA. Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology. Drug Test Anal. 2014 Jul-Aug; 6(7-8):728-38. PMID: 24659527.
      Citations:    
    245. Newmeyer MN, Desrosiers NA, Lee D, Mendu DR, Barnes AJ, Gorelick DA, Huestis MA. Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers. Drug Test Anal. 2014 Oct; 6(10):1002-10. PMID: 24652685.
      Citations:    
    246. Diaz SD, Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis MA, Della Grotta S, Dansereau LM, Neal C, Lester BM. Effects of prenatal methamphetamine exposure on behavioral and cognitive findings at 7.5 years of age. J Pediatr. 2014 Jun; 164(6):1333-8. PMID: 24630350.
      Citations:    
    247. Wouldes TA, Lagasse LL, Huestis MA, Dellagrotta S, Dansereau LM, Lester BM. Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3 years. Neurotoxicol Teratol. 2014 Mar-Apr; 42:77-84. PMID: 24566524.
      Citations:    
    248. Desrosiers NA, Himes SK, Scheidweiler KB, Concheiro-Guisan M, Gorelick DA, Huestis MA. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. Clin Chem. 2014 Apr; 60(4):631-43. PMID: 24563491.
      Citations:    
    249. Wohlfarth A, Gandhi AS, Pang S, Zhu M, Scheidweiler KB, Huestis MA. Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry. Anal Bioanal Chem. 2014 Feb; 406(6):1763-80. PMID: 24518903.
      Citations:    
    250. Himes SK, Concheiro M, Scheidweiler KB, Huestis MA. Validation of a novel method to identify in utero ethanol exposure: simultaneous meconium extraction of fatty acid ethyl esters, ethyl glucuronide, and ethyl sulfate followed by LC-MS/MS quantification. Anal Bioanal Chem. 2014 Mar; 406(7):1945-55. PMID: 24408304.
      Citations:    
    251. Castaneto MS, Desrosiers NA, Ellefsen K, Anizan S, Martin TM, Klette KL, Huestis MA. Method validation of the biochip array technology for synthetic cannabinoids detection in urine. Bioanalysis. 2014; 6(21):2919-30. PMID: 25486237.
      Citations:    
    252. Kiblawi ZN, Smith LM, Diaz SD, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis M, Haning W, Strauss A, DellaGrotta S, Dansereau LM, Neal C, Lester B. Prenatal methamphetamine exposure and neonatal and infant neurobehavioral outcome: results from the IDEAL study. Subst Abus. 2014; 35(1):68-73. PMID: 24588296.
      Citations:    
    253. Scheidweiler KB, Huestis MA. Simultaneous quantification of 20 synthetic cannabinoids and 21 metabolites, and semi-quantification of 12 alkyl hydroxy metabolites in human urine by liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2014 Jan 31; 1327:105-17. PMID: 24418231.
      Citations:    
    254. Koola MM, Gorelick DA, McMahon RP, Liu F, Huestis MA, Linthicum J, Feldman SM, Warren KR, Wehring HJ, Kelly DL. Psychiatric symptom differences in people with schizophrenia associated with substantial lifetime substance use but no current substance use disorder. Schizophr Res. 2014 Jan; 152(1):315-6. PMID: 24333005.
      Citations:    
    255. Bergamaschi MM, Queiroz RH, Chagas MH, Linares IM, Arrais KC, de Oliveira DC, Queiroz ME, Nardi AE, Huestis MA, Hallak JE, Zuardi AW, Moreira FA, Crippa JA. Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report. Hum Psychopharmacol. 2014 Jan; 29(1):94-9. PMID: 24424711.
      Citations:    
    256. Desrosiers NA, Lee D, Scheidweiler KB, Concheiro-Guisan M, Gorelick DA, Huestis MA. In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis. Anal Bioanal Chem. 2014 Jan; 406(3):785-92. PMID: 24292435.
      Citations:    
    257. Castaneto MS, Barnes AJ, Scheidweiler KB, Schaffer M, Rogers KK, Stewart D, Huestis MA. Identifying methamphetamine exposure in children. Ther Drug Monit. 2013 Dec; 35(6):823-30. PMID: 24263642.
      Citations:    
    258. Hartman RL, Desrosiers NA, Barnes AJ, Yun K, Scheidweiler KB, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA. 3,4-Methylenedioxymethamphetamine (MDMA) and metabolites disposition in blood and plasma following controlled oral administration. Anal Bioanal Chem. 2014 Jan; 406(2):587-99. PMID: 24232751.
      Citations:    
    259. Desrosiers NA, Lee D, Concheiro-Guisan M, Scheidweiler KB, Gorelick DA, Huestis MA. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers? Clin Chem. 2014 Feb; 60(2):361-72. PMID: 24185550.
      Citations:    
    260. Anizan S, Huestis MA. The potential role of oral fluid in antidoping testing. Clin Chem. 2014 Feb; 60(2):307-22. PMID: 24153253.
      Citations:    
    261. Concheiro M, Baumann MH, Scheidweiler KB, Rothman RB, Marrone GF, Huestis MA. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat. Drug Metab Dispos. 2014 Jan; 42(1):119-25. PMID: 24141857.
      Citations:    
    262. Concheiro M, Anizan S, Ellefsen K, Huestis MA. Simultaneous quantification of 28 synthetic cathinones and metabolites in urine by liquid chromatography-high resolution mass spectrometry. Anal Bioanal Chem. 2013 Nov; 405(29):9437-48. PMID: 24196122.
      Citations:    
    263. Himes SK, Scheidweiler KB, Beck O, Gorelick DA, Desrosiers NA, Huestis MA. Cannabinoids in exhaled breath following controlled administration of smoked cannabis. Clin Chem. 2013 Dec; 59(12):1780-9. PMID: 24046200.
      Citations:    
    264. Wohlfarth A, Pang S, Zhu M, Gandhi AS, Scheidweiler KB, Liu HF, Huestis MA. First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry. Clin Chem. 2013 Nov; 59(11):1638-48. PMID: 24014837.
      Citations:    
    265. Gorelick DA, Goodwin RS, Schwilke E, Schroeder JR, Schwope DM, Kelly DL, Ortemann-Renon C, Bonnet D, Huestis MA. Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers. Am J Addict. 2013 Sep-Oct; 22(5):510-4. PMID: 23952899.
      Citations:    
    266. Lee D, Huestis MA. Current knowledge on cannabinoids in oral fluid. Drug Test Anal. 2014 Jan-Feb; 6(1-2):88-111. PMID: 23983217.
      Citations:    
    267. Anizan S, Milman G, Desrosiers N, Barnes AJ, Gorelick DA, Huestis MA. Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers. Anal Bioanal Chem. 2013 Oct; 405(26):8451-61. PMID: 23954944.
      Citations:    
    268. Lee D, Vandrey R, Mendu DR, Anizan S, Milman G, Murray JA, Barnes AJ, Huestis MA. Oral fluid cannabinoids in chronic cannabis smokers during oral d9-tetrahydrocannabinol therapy and smoked cannabis challenge. Clin Chem. 2013 Dec; 59(12):1770-9. PMID: 23938457.
      Citations:    
    269. Gandhi AS, Zhu M, Pang S, Wohlfarth A, Scheidweiler KB, Liu HF, Huestis MA. First characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometry. AAPS J. 2013 Oct; 15(4):1091-8. PMID: 23913126.
      Citations:    
    270. Lee D, Vandrey R, Milman G, Bergamaschi M, Mendu DR, Murray JA, Barnes AJ, Huestis MA. Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration. Anal Bioanal Chem. 2013 Sep; 405(23):7269-79. PMID: 23831756.
      Citations:    
    271. Scheidweiler KB, Himes SK, Chen X, Liu HF, Huestis MA. 11-Nor-9-carboxy-?9-tetrahydrocannabinol quantification in human oral fluid by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2013 Jul; 405(18):6019-27. PMID: 23681203.
      Citations:    
    272. Hahn B, Harvey AN, Concheiro-Guisan M, Huestis MA, Holcomb HH, Gold JM. A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia. Biol Psychiatry. 2013 Sep 15; 74(6):436-43. PMID: 23660272.
      Citations:    
    273. Kirlic N, Newman E, Lagasse LL, Derauf C, Shah R, Smith LM, Arria AM, Huestis MA, Haning W, Strauss A, Dellagrotta S, Dansereau LM, Abar B, Neal CR, Lester BM. Cortisol reactivity in two-year-old children prenatally exposed to methamphetamine. J Stud Alcohol Drugs. 2013 May; 74(3):447-51. PMID: 23490574.
      Citations:    
    274. Concheiro M, Lee D, Lendoiro E, Huestis MA. Simultaneous quantification of ?(9)-tetrahydrocannabinol, 11-nor-9-carboxy-tetrahydrocannabinol, cannabidiol and cannabinol in oral fluid by microflow-liquid chromatography-high resolution mass spectrometry. J Chromatogr A. 2013 Jul 05; 1297:123-30. PMID: 23726246.
      Citations:    
    275. Eiden RD, Homish GG, Colder CR, Schuetze P, Gray TR, Huestis MA. Changes in smoking patterns during pregnancy. Subst Use Misuse. 2013 May; 48(7):513-22. PMID: 23581507.
      Citations:    
    276. Zanotti-Fregonara P, Hirvonen J, Lyoo CH, Zoghbi SS, Rallis-Frutos D, Huestis MA, Morse C, Pike VW, Innis RB. Population-based input function modeling for [(18)F]FMPEP-d 2, an inverse agonist radioligand for cannabinoid CB1 receptors: validation in clinical studies. PLoS One. 2013; 8(4):e60231. PMID: 23577094.
      Citations:    
    277. Wu M, Lagasse LL, Wouldes TA, Arria AM, Wilcox T, Derauf C, Newman E, Shah R, Smith LM, Neal CR, Huestis MA, Dellagrotta S, Lester BM. Predictors of inadequate prenatal care in methamphetamine-using mothers in New Zealand and the United States. Matern Child Health J. 2013 Apr; 17(3):566-75. PMID: 22588827.
      Citations:    
    278. Muniyappa R, Sable S, Ouwerkerk R, Mari A, Gharib AM, Walter M, Courville A, Hall G, Chen KY, Volkow ND, Kunos G, Huestis MA, Skarulis MC. Metabolic effects of chronic cannabis smoking. Diabetes Care. 2013 Aug; 36(8):2415-22. PMID: 23530011.
      Citations:    
    279. Scheidweiler KB, Schwope DM, Karschner EL, Desrosiers NA, Gorelick DA, Huestis MA. In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis. Clin Chem. 2013 Jul; 59(7):1108-17. PMID: 23519966.
      Citations:    
    280. Wohlfarth A, Scheidweiler KB, Chen X, Liu HF, Huestis MA. Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search. Anal Chem. 2013 Apr 02; 85(7):3730-8. PMID: 23458260.
      Citations:    
    281. Bergamaschi MM, Barnes A, Queiroz RH, Hurd YL, Huestis MA. Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine. Anal Bioanal Chem. 2013 May; 405(14):4679-89. PMID: 23494274.
      Citations:    
    282. Desrosiers NA, Barnes AJ, Hartman RL, Scheidweiler KB, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA. Oral fluid and plasma 3,4-methylenedioxymethamphetamine (MDMA) and metabolite correlation after controlled oral MDMA administration. Anal Bioanal Chem. 2013 May; 405(12):4067-76. PMID: 23471370.
      Citations:    
    283. Bergamaschi MM, Karschner EL, Goodwin RS, Scheidweiler KB, Hirvonen J, Queiroz RH, Huestis MA. Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws. Clin Chem. 2013 Mar; 59(3):519-26. PMID: 23449702.
      Citations:    
    284. Warren KR, Buchanan RW, Feldman S, Conley RR, Linthicum J, Ball MP, Liu F, McMahon RP, Gorelick DA, Huestis MA, Kelly DL. Effects of the cannabinoid-1 receptor antagonist/inverse agonist rimonabant on satiety signaling in overweight people with schizophrenia: a randomized, double-blind, pilot study. J Clin Psychopharmacol. 2013 Feb; 33(1):118-20. PMID: 23277241.
      Citations:    
    285. Himes SK, Scheidweiler KB, Tassiopoulos K, Kacanek D, Hazra R, Rich K, Huestis MA. Development and validation of the first liquid chromatography-tandem mass spectrometry assay for simultaneous quantification of multiple antiretrovirals in meconium. Anal Chem. 2013 Feb 05; 85(3):1896-904. PMID: 23256731.
      Citations:    
    286. Bosker WM, Karschner EL, Lee D, Goodwin RS, Hirvonen J, Innis RB, Theunissen EL, Kuypers KP, Huestis MA, Ramaekers JG. Psychomotor function in chronic daily Cannabis smokers during sustained abstinence. PLoS One. 2013; 8(1):e53127. PMID: 23301031.
      Citations:    
    287. Schuetze P, Eiden RD, Colder CR, Gray TR, Huestis MA. Physiological Regulation at 9 Months of Age in Infants Prenatally Exposed to Cigarettes. Infancy. 2013; 18(2):233-255. PMID: 23646002.
      Citations:    
    288. Kiblawi ZN, Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis M, DellaGrotta S, Dansereau LM, Neal C, Lester B. The effect of prenatal methamphetamine exposure on attention as assessed by continuous performance tests: results from the Infant Development, Environment, and Lifestyle study. J Dev Behav Pediatr. 2013 Jan; 34(1):31-7. PMID: 23275056.
      Citations:    
    289. Twomey J, LaGasse L, Derauf C, Newman E, Shah R, Smith L, Arria A, Huestis M, DellaGrotta S, Roberts M, Dansereau L, Neal C, Lester B. Prenatal methamphetamine exposure, home environment, and primary caregiver risk factors predict child behavioral problems at 5 years. Am J Orthopsychiatry. 2013 Jan; 83(1):64-72. PMID: 23330624.
      Citations:    
    290. Huestis MA, Cone EJ, Pirnay SO, Umbricht A, Preston KL. Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans. Drug Alcohol Depend. 2013 Aug 01; 131(3):258-62. PMID: 23246635.
      Citations:    
    291. Hartman RL, Huestis MA. Cannabis effects on driving skills. Clin Chem. 2013 Mar; 59(3):478-92. PMID: 23220273.
      Citations:    
    292. Himes SK, Stroud LR, Scheidweiler KB, Niaura RS, Huestis MA. Prenatal tobacco exposure, biomarkers for tobacco in meconium, and neonatal growth outcomes. J Pediatr. 2013 May; 162(5):970-5. PMID: 23211926.
      Citations:    
    293. Liles BD, Newman E, Lagasse LL, Derauf C, Shah R, Smith LM, Arria AM, Huestis MA, Haning W, Strauss A, Dellagrotta S, Dansereau LM, Neal C, Lester BM. Perceived child behavior problems, parenting stress, and maternal depressive symptoms among prenatal methamphetamine users. Child Psychiatry Hum Dev. 2012 Dec; 43(6):943-57. PMID: 22552952.
      Citations:    
    294. Lee D, Karschner EL, Milman G, Barnes AJ, Goodwin RS, Huestis MA. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? Drug Alcohol Depend. 2013 Jun 01; 130(1-3):68-76. PMID: 23146820.
      Citations:    
    295. Gorelick DA, Goodwin RS, Schwilke E, Schwope DM, Darwin WD, Kelly DL, McMahon RP, Liu F, Ortemann-Renon C, Bonnet D, Huestis MA. Tolerance to effects of high-dose oral d9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers. J Anal Toxicol. 2013 Jan-Feb; 37(1):11-6. PMID: 23074216.
      Citations:    
    296. Abar B, LaGasse LL, Derauf C, Newman E, Shah R, Smith LM, Arria A, Huestis M, Della Grotta S, Dansereau LM, Neal C, Lester BM. Examining the relationships between prenatal methamphetamine exposure, early adversity, and child neurobehavioral disinhibition. Psychol Addict Behav. 2013 Sep; 27(3):662-73. PMID: 23067308.
      Citations:    
    297. Rose EJ, Ross TJ, Salmeron BJ, Lee M, Shakleya DM, Huestis MA, Stein EA. Acute nicotine differentially impacts anticipatory valence- and magnitude-related striatal activity. Biol Psychiatry. 2013 Feb 01; 73(3):280-8. PMID: 22939991.
      Citations:    
    298. Vandrey R, Stitzer ML, Mintzer MZ, Huestis MA, Murray JA, Lee D. The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug Alcohol Depend. 2013 Feb 01; 128(1-2):64-70. PMID: 22921474.
      Citations:    
    299. Desrosiers NA, Lee D, Schwope DM, Milman G, Barnes AJ, Gorelick DA, Huestis MA. On-site test for cannabinoids in oral fluid. Clin Chem. 2012 Oct; 58(10):1418-25. PMID: 22912396.
      Citations:    
    300. Wouldes TA, LaGasse LL, Derauf C, Newman E, Shah R, Smith LM, Arria AM, Huestis MA, DellaGrotta S, Wilcox T, Neal CR, Lester BM. Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand. Drug Alcohol Depend. 2013 Jan 01; 127(1-3):101-7. PMID: 22789630.
      Citations:    
    301. Scheidweiler KB, Desrosiers NA, Huestis MA. Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry. Clin Chim Acta. 2012 Nov 20; 413(23-24):1839-47. PMID: 22771478.
      Citations:    
    302. Himes SK, Goodwin RS, Rock CM, Jones HE, Johnson RE, Wilkins DG, Huestis MA. Methadone and metabolites in hair of methadone-assisted pregnant women and their infants. Ther Drug Monit. 2012 Jun; 34(3):337-44. PMID: 22495425.
      Citations:    
    303. Haymond S, Saenger AK, Free HM, Hicks JM, Huestis MA, Horvath AR, Fantz CR. Altering the landscape for women in clinical chemistry: perspectives from multigenerational leaders. Clin Chem. 2012 Jul; 58(7):1082-5. PMID: 22623746.
      Citations:    
    304. Ropero-Miller JD, Huestis MA, Stout PR. Cocaine analytes in human hair: evaluation of concentration ratios in different cocaine sources, drug-user populations and surface-contaminated specimens. J Anal Toxicol. 2012 Jul; 36(6):390-8. PMID: 22593566.
      Citations:    
    305. Schwope DM, Bosker WM, Ramaekers JG, Gorelick DA, Huestis MA. Psychomotor performance, subjective and physiological effects and whole blood ??-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis. J Anal Toxicol. 2012 Jul; 36(6):405-12. PMID: 22589524.
      Citations:    
    306. Smith LM, Paz MS, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis MA, Haning W, Strauss A, Della Grotta S, Dansereau LM, Neal C, Lester BM. Maternal depression and prenatal exposure to methamphetamine: neurodevelopmental findings from the infant development, environment, and lifestyle (ideal) study. Depress Anxiety. 2012 Jun; 29(6):515-22. PMID: 22555777.
      Citations:    
    307. Lee D, Milman G, Schwope DM, Barnes AJ, Gorelick DA, Huestis MA. Cannabinoid stability in authentic oral fluid after controlled cannabis smoking. Clin Chem. 2012 Jul; 58(7):1101-9. PMID: 22532594.
      Citations:    
    308. Karschner EL, Schwope DM, Schwilke EW, Goodwin RS, Kelly DL, Gorelick DA, Huestis MA. Predictive model accuracy in estimating last ?9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC. Drug Alcohol Depend. 2012 Oct 01; 125(3):313-9. PMID: 22464363.
      Citations:    
    309. LaGasse LL, Derauf C, Smith LM, Newman E, Shah R, Neal C, Arria A, Huestis MA, DellaGrotta S, Lin H, Dansereau LM, Lester BM. Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics. 2012 Apr; 129(4):681-8. PMID: 22430455.
      Citations:    
    310. Derauf C, Lagasse LL, Smith LM, Newman E, Shah R, Neal CR, Arria AM, Huestis MA, Dellagrotta S, Dansereau LM, Lin H, Lester BM. Prenatal methamphetamine exposure and inhibitory control among young school-age children. J Pediatr. 2012 Sep; 161(3):452-9. PMID: 22424953.
      Citations:    
    311. Shah R, Diaz SD, Arria A, LaGasse LL, Derauf C, Newman E, Smith LM, Huestis MA, Haning W, Strauss A, Della Grotta S, Dansereau LM, Roberts MB, Neal C, Lester BM. Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes. Am J Perinatol. 2012 May; 29(5):391-400. PMID: 22399214.
      Citations:    
    312. Scheidweiler KB, Shakleya DM, Huestis MA. Simultaneous quantification of nicotine, cotinine, trans-3'-hydroxycotinine, norcotinine and mecamylamine in human urine by liquid chromatography-tandem mass spectrometry. Clin Chim Acta. 2012 Jun 14; 413(11-12):978-84. PMID: 22394455.
      Citations:    
    313. Polettini A, Cone EJ, Gorelick DA, Huestis MA. Incorporation of methamphetamine and amphetamine in human hair following controlled oral methamphetamine administration. Anal Chim Acta. 2012 May 13; 726:35-43. PMID: 22541011.
      Citations:    
    314. Lee D, Schwope DM, Milman G, Barnes AJ, Gorelick DA, Huestis MA. Cannabinoid disposition in oral fluid after controlled smoked cannabis. Clin Chem. 2012 Apr; 58(4):748-56. PMID: 22273566.
      Citations:    
    315. Milman G, Schwope DM, Gorelick DA, Huestis MA. Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis. Clin Chim Acta. 2012 Apr 11; 413(7-8):765-70. PMID: 22285315.
      Citations:    
    316. Boggs DL, Kelly DL, McMahon RP, Gold JM, Gorelick DA, Linthicum J, Conley RR, Liu F, Waltz J, Huestis MA, Buchanan RW. Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial. Schizophr Res. 2012 Feb; 134(2-3):207-10. PMID: 22137462.
      Citations:    
    317. Eiden RD, Leonard KE, Colder CR, Homish GG, Schuetze P, Gray TR, Huestis MA. Anger, hostility, and aggression as predictors of persistent smoking during pregnancy. J Stud Alcohol Drugs. 2011 Nov; 72(6):926-32. PMID: 22051206.
      Citations:    
    318. Huestis MA, Mazzoni I, Rabin O. Cannabis in sport: anti-doping perspective. Sports Med. 2011 Nov 01; 41(11):949-66. PMID: 21985215.
      Citations:    
    319. Rose EJ, Ross TJ, Salmeron BJ, Lee M, Shakleya DM, Huestis M, Stein EA. Chronic exposure to nicotine is associated with reduced reward-related activity in the striatum but not the midbrain. Biol Psychiatry. 2012 Feb 01; 71(3):206-13. PMID: 22032832.
      Citations:    
    320. Schwaninger AE, Meyer MR, Barnes AJ, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA, Maurer HH. Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration. Clin Chem. 2011 Dec; 57(12):1748-56. PMID: 21980168.
      Citations:    
    321. Gorelick DA, Goodwin RS, Schwilke E, Schwope DM, Darwin WD, Kelly DL, McMahon RP, Liu F, Ortemann-Renon C, Bonnet D, Huestis MA. Antagonist-elicited cannabis withdrawal in humans. J Clin Psychopharmacol. 2011 Oct; 31(5):603-12. PMID: 21869692.
      Citations:    
    322. Barnes AJ, Scheidweiler KB, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA. MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration. Ther Drug Monit. 2011 Oct; 33(5):602-8. PMID: 21860342.
      Citations:    
    323. Scheidweiler KB, Marrone GF, Shakleya DM, Singleton EG, Heishman SJ, Huestis MA. Oral fluid nicotine markers to assess smoking status and recency of use. Ther Drug Monit. 2011 Oct; 33(5):609-18. PMID: 21860341.
      Citations:    
    324. Concheiro M, Jones HE, Johnson RE, Choo R, Huestis MA. Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women. Ther Drug Monit. 2011 Oct; 33(5):619-26. PMID: 21860340.
      Citations:    
    325. Schwaninger AE, Meyer MR, Barnes AJ, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA, Maurer HH. Stereoselective urinary MDMA (ecstasy) and metabolites excretion kinetics following controlled MDMA administration to humans. Biochem Pharmacol. 2012 Jan 01; 83(1):131-8. PMID: 21983032.
      Citations:    
    326. Scheidweiler KB, Ladenheim B, Barnes AJ, Cadet JL, Huestis MA. (?)-3,4-methylenedioxymethamphetamine and metabolite disposition in plasma and striatum of wild-type and multidrug resistance protein 1a knock-out mice. J Anal Toxicol. 2011 Sep; 35(7):470-80. PMID: 21871156.
      Citations:    
    327. Milman G, Schwope DM, Schwilke EW, Darwin WD, Kelly DL, Goodwin RS, Gorelick DA, Huestis MA. Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral ?(9)-tetrahydrocannabinol administration. Clin Chem. 2011 Nov; 57(11):1597-606. PMID: 21875944.
      Citations:    
    328. Schwope DM, Karschner EL, Gorelick DA, Huestis MA. Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. Clin Chem. 2011 Oct; 57(10):1406-14. PMID: 21836075.
      Citations:    
    329. Zabaneh R, Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Dansereau LM, Lin H, Neal C, Lester BM. The effects of prenatal methamphetamine exposure on childhood growth patterns from birth to 3 years of age. Am J Perinatol. 2012 Mar; 29(3):203-10. PMID: 21818727.
      Citations:    
    330. de Castro A, Jones HE, Johnson RE, Gray TR, Shakleya DM, Huestis MA. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes. Ther Drug Monit. 2011 Aug; 33(4):443-52. PMID: 21743375.
      Citations:    
    331. Goodwin RS, Baumann MH, Gorelick DA, Schwilke E, Schwope DM, Darwin WD, Kelly DL, Schroeder JR, Ortemann-Renon C, Bonnet D, Huestis MA. CB1 - cannabinoid receptor antagonist effects on cortisol in cannabis-dependent men. Am J Drug Alcohol Abuse. 2012 Jan; 38(1):114-9. PMID: 21797816.
      Citations:    
    332. Donovan DM, Bigelow GE, Brigham GS, Carroll KM, Cohen AJ, Gardin JG, Hamilton JA, Huestis MA, Hughes JR, Lindblad R, Marlatt GA, Preston KL, Selzer JA, Somoza EC, Wakim PG, Wells EA. Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction. 2012 Apr; 107(4):694-708. PMID: 21781202.
      Citations:    
    333. Schuetze P, Eiden RD, Colder CR, Gray TR, Huestis MA. Physiological regulation in cigarette exposed infants: an examination of potential moderators. Neurotoxicol Teratol. 2011 Sep-Oct; 33(5):567-74. PMID: 21798345.
      Citations:    
    334. Holland MG, Schwope DM, Stoppacher R, Gillen SB, Huestis MA. Postmortem redistribution of ?9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH). Forensic Sci Int. 2011 Oct 10; 212(1-3):247-51. PMID: 21764230.
      Citations:    
    335. Hirvonen J, Goodwin RS, Li CT, Terry GE, Zoghbi SS, Morse C, Pike VW, Volkow ND, Huestis MA, Innis RB. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry. 2012 Jun; 17(6):642-9. PMID: 21747398.
      Citations:    
    336. Schwope DM, Scheidweiler KB, Huestis MA. Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2011 Sep; 401(4):1273-83. PMID: 21727996.
      Citations:    
    337. Schwaninger AE, Meyer MR, Huestis MA, Maurer HH. Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine. J Mass Spectrom. 2011 Jul; 46(7):603-14. PMID: 21656610.
      Citations:    
    338. Lee D, Milman G, Barnes AJ, Goodwin RS, Hirvonen J, Huestis MA. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence. Clin Chem. 2011 Aug; 57(8):1127-36. PMID: 21677094.
      Citations:    
    339. Milman G, Barnes AJ, Schwope DM, Schwilke EW, Goodwin RS, Kelly DL, Gorelick DA, Huestis MA. Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration. Anal Bioanal Chem. 2011 Aug; 401(2):599-607. PMID: 21637933.
      Citations:    
    340. Marrone GF, Shakleya DM, Scheidweiler KB, Singleton EG, Huestis MA, Heishman SJ. Relative performance of common biochemical indicators in detecting cigarette smoking. Addiction. 2011 Jul; 106(7):1325-34. PMID: 21438939.
      Citations:    
    341. Huestis MA, Verstraete A, Kwong TC, Morland J, Vincent MJ, de la Torre R. Oral fluid testing: promises and pitfalls. Clin Chem. 2011 Jun; 57(6):805-10. PMID: 21350039.
      Citations:    
    342. Karschner EL, Darwin WD, McMahon RP, Liu F, Wright S, Goodwin RS, Huestis MA. Subjective and physiological effects after controlled Sativex and oral THC administration. Clin Pharmacol Ther. 2011 Mar; 89(3):400-7. PMID: 21289620.
      Citations:    
    343. Derauf C, LaGasse L, Smith L, Newman E, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Dansereau L, Lin H, Lester B. Infant temperament and high-risk environment relate to behavior problems and language in toddlers. J Dev Behav Pediatr. 2011 Feb-Mar; 32(2):125-35. PMID: 21200329.
      Citations:    
    344. Kelly DL, Gorelick DA, Conley RR, Boggs DL, Linthicum J, Liu F, Feldman S, Ball MP, Wehring HJ, McMahon RP, Huestis MA, Heishman SJ, Warren KR, Buchanan RW. Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study. J Clin Psychopharmacol. 2011 Feb; 31(1):86-91. PMID: 21192149.
      Citations:    
    345. de Castro A, Jones HE, Johnson RE, Gray TR, Shakleya DM, Huestis MA. Maternal methadone dose, placental methadone concentrations, and neonatal outcomes. Clin Chem. 2011 Mar; 57(3):449-58. PMID: 21245372.
      Citations:    
    346. Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Haning W, Arria A, Huestis M, Strauss A, Della Grotta S, Dansereau LM, Lin H, Lester BM. Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine. Neurotoxicol Teratol. 2011 Jan-Feb; 33(1):176-84. PMID: 21256431.
      Citations:    
    347. Schwilke EW, Gullberg RG, Darwin WD, Chiang CN, Cadet JL, Gorelick DA, Pope HG, Huestis MA. Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users. Addiction. 2011 Mar; 106(3):499-506. PMID: 21134021.
      Citations:    
    348. Concheiro M, Shakleya DM, Huestis MA. Simultaneous analysis of buprenorphine, methadone, cocaine, opiates and nicotine metabolites in sweat by liquid chromatography tandem mass spectrometry. Anal Bioanal Chem. 2011 Apr; 400(1):69-78. PMID: 21125263.
      Citations:    
    349. Karschner EL, Darwin WD, Goodwin RS, Wright S, Huestis MA. Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration. Clin Chem. 2011 Jan; 57(1):66-75. PMID: 21078841.
      Citations:    
    350. Delaney-Black V, Chiodo LM, Hannigan JH, Greenwald MK, Janisse J, Patterson G, Huestis MA, Ager J, Sokol RJ. Just say "I don't": lack of concordance between teen report and biological measures of drug use. Pediatrics. 2010 Nov; 126(5):887-93. PMID: 20974792.
      Citations:    
    351. Scheidweiler KB, Spargo EA, Kelly TL, Cone EJ, Barnes AJ, Huestis MA. Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administration. Ther Drug Monit. 2010 Oct; 32(5):628-37. PMID: 20814350.
      Citations:    
    352. Concheiro M, Jones HE, Johnson RE, Choo R, Shakleya DM, Huestis MA. Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes. J Anal Toxicol. 2010 Oct; 34(8):498-505. PMID: 21819795.
      Citations:    
    353. Sutherland MT, Ross TJ, Shakleya DM, Huestis MA, Stein EA. Chronic smoking, but not acute nicotine administration, modulates neural correlates of working memory. Psychopharmacology (Berl). 2011 Jan; 213(1):29-42. PMID: 20862456.
      Citations:    
    354. Gray TR, Choo RE, Concheiro M, Williams E, Elko A, Jansson LM, Jones HE, Huestis MA. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome. Addiction. 2010 Dec; 105(12):2151-9. PMID: 20854338.
      Citations:    
    355. Copersino ML, Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Sociodemographic characteristics of cannabis smokers and the experience of cannabis withdrawal. Am J Drug Alcohol Abuse. 2010 Nov; 36(6):311-9. PMID: 20678028.
      Citations:    
    356. Barnes AJ, Brunet BR, Choo RE, Mura P, Johnson RE, Jones HE, Huestis MA. Excretion of methadone in sweat of pregnant women throughout gestation after controlled methadone administration. Ther Drug Monit. 2010 Aug; 32(4):497-503. PMID: 20592651.
      Citations:    
    357. Gray TR, Dams R, Choo RE, Jones HE, Huestis MA. Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence. Forensic Sci Int. 2011 Mar 20; 206(1-3):98-102. PMID: 20667673.
      Citations:    
    358. Concheiro M, Gray TR, Shakleya DM, Huestis MA. High-throughput simultaneous analysis of buprenorphine, methadone, cocaine, opiates, nicotine, and metabolites in oral fluid by liquid chromatography tandem mass spectrometry. Anal Bioanal Chem. 2010 Sep; 398(2):915-24. PMID: 20652688.
      Citations:    
    359. Gray TR, Eiden RD, Leonard KE, Connors GJ, Shisler S, Huestis MA. Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. Clin Chem. 2010 Sep; 56(9):1442-50. PMID: 20628142.
      Citations:    
    360. Delaney-Black V, Chiodo LM, Hannigan JH, Greenwald MK, Janisse J, Patterson G, Huestis MA, Partridge RT, Ager J, Sokol RJ. Prenatal and postnatal cocaine exposure predict teen cocaine use. Neurotoxicol Teratol. 2011 Jan-Feb; 33(1):110-9. PMID: 20609384.
      Citations:    
    361. LaGasse LL, Wouldes T, Newman E, Smith LM, Shah RZ, Derauf C, Huestis MA, Arria AM, Della Grotta S, Wilcox T, Lester BM. Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. Neurotoxicol Teratol. 2011 Jan-Feb; 33(1):166-75. PMID: 20615464.
      Citations:    
    362. Nguyen D, Smith LM, Lagasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis MA, Haning W, Strauss A, Della Grotta S, Liu J, Lester BM. Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study. J Pediatr. 2010 Aug; 157(2):337-9. PMID: 20570284.
      Citations:    
    363. Milman G, Barnes AJ, Schwope DM, Schwilke EW, Darwin WD, Goodwin RS, Kelly DL, Gorelick DA, Huestis MA. Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration. Clin Chem. 2010 Aug; 56(8):1261-9. PMID: 20530732.
      Citations:    
    364. Gray TR, Barnes AJ, Huestis MA. Effect of hydrolysis on identifying prenatal cannabis exposure. Anal Bioanal Chem. 2010 Jul; 397(6):2335-47. PMID: 20517601.
      Citations:    
    365. Gray TR, Eiden RD, Leonard KE, Connors G, Shisler S, Huestis MA. Nicotine and metabolites in meconium as evidence of maternal cigarette smoking during pregnancy and predictors of neonatal growth deficits. Nicotine Tob Res. 2010 Jun; 12(6):658-64. PMID: 20427459.
      Citations:    
    366. Schwope DM, Milman G, Huestis MA. Validation of an enzyme immunoassay for detection and semiquantification of cannabinoids in oral fluid. Clin Chem. 2010 Jun; 56(6):1007-14. PMID: 20360126.
      Citations:    
    367. Concheiro M, Jones HE, Johnson RE, Choo R, Shakleya DM, Huestis MA. Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes. Ther Drug Monit. 2010 Apr; 32(2):206-15. PMID: 20216119.
      Citations:    
    368. Karschner EL, Barnes AJ, Lowe RH, Scheidweiler KB, Huestis MA. Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma. Anal Bioanal Chem. 2010 May; 397(2):603-11. PMID: 20306180.
      Citations:    
    369. Smith ML, Shimomura E, Paul BD, Cone EJ, Darwin WD, Huestis MA. Urinary excretion of ecgonine and five other cocaine metabolites following controlled oral, intravenous, intranasal, and smoked administration of cocaine. J Anal Toxicol. 2010 Mar; 34(2):57-63. PMID: 20223096.
      Citations:    
    370. Gray TR, Kelly T, LaGasse LL, Smith LM, Derauf C, Grant P, Shah R, Arria A, Haning W, Della Grotta S, Strauss A, Lester BM, Huestis MA. New meconium biomarkers of prenatal methamphetamine exposure increase identification of affected neonates. Clin Chem. 2010 May; 56(5):856-60. PMID: 20185623.
      Citations:    
    371. Brunet BR, Barnes AJ, Choo RE, Mura P, Jones HE, Huestis MA. Monitoring pregnant women's illicit opiate and cocaine use with sweat testing. Ther Drug Monit. 2010 Feb; 32(1):40-9. PMID: 19927046.
      Citations:    
    372. Milman G, Barnes AJ, Lowe RH, Huestis MA. Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry. J Chromatogr A. 2010 Feb 26; 1217(9):1513-21. PMID: 20083251.
      Citations:    
    373. Shakleya DM, Dams R, Choo RE, Jones H, Huestis MA. Simultaneous liquid chromatography-mass spectrometry quantification of urinary opiates, cocaine, and metabolites in opiate-dependent pregnant women in methadone-maintenance treatment. J Anal Toxicol. 2010 Jan-Feb; 34(1):17-25. PMID: 20109298.
      Citations:    
    374. Concheiro M, Jones H, Johnson RE, Shakleya DM, Huestis MA. Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Jan 01; 878(1):13-20. PMID: 19945361.
      Citations:    
    375. Gray TR, LaGasse LL, Smith LM, Derauf C, Grant P, Shah R, Arria AM, Della Grotta SA, Strauss A, Haning WF, Lester BM, Huestis MA. Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study. Ther Drug Monit. 2009 Dec; 31(6):769-75. PMID: 19935364.
      Citations:    
    376. Westin AA, Huestis MA, Aarstad K, Spigset O. Short communication: Urinary excretion of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol in a pregnant woman following heavy, chronic cannabis use. J Anal Toxicol. 2009 Nov-Dec; 33(9):610-4. PMID: 20040136.
      Citations:    
    377. Scheidweiler KB, Ladenheim B, Cadet JL, Huestis MA. Mice lacking multidrug resistance protein 1a show altered dopaminergic responses to methylenedioxymethamphetamine (MDMA) in striatum. Neurotox Res. 2010 Aug; 18(2):200-9. PMID: 19851718.
      Citations:    
    378. Shakleya DM, Huestis MA. Optimization and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human oral fluid. Anal Bioanal Chem. 2009 Dec; 395(7):2349-57. PMID: 19838828.
      Citations:    
    379. Huestis MA. A new ultraperformance-tandem mass spectrometry oral fluid assay for 29 illicit drugs and medications. Clin Chem. 2009 Dec; 55(12):2079-81. PMID: 19833833.
      Citations:    
    380. Schwilke EW, Schwope DM, Karschner EL, Lowe RH, Darwin WD, Kelly DL, Goodwin RS, Gorelick DA, Huestis MA. Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC. Clin Chem. 2009 Dec; 55(12):2180-9. PMID: 19833841.
      Citations:    
    381. Karschner EL, Schwilke EW, Lowe RH, Darwin WD, Pope HG, Herning R, Cadet JL, Huestis MA. Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? Addiction. 2009 Dec; 104(12):2041-8. PMID: 19804462.
      Citations:    
    382. Karschner EL, Schwilke EW, Lowe RH, Darwin WD, Herning RI, Cadet JL, Huestis MA. Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers. J Anal Toxicol. 2009 Oct; 33(8):469-77. PMID: 19874654.
      Citations:    
    383. Abraham TT, Barnes AJ, Lowe RH, Kolbrich Spargo EA, Milman G, Pirnay SO, Gorelick DA, Goodwin RS, Huestis MA. Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans. J Anal Toxicol. 2009 Oct; 33(8):439-46. PMID: 19874650.
      Citations:    
    384. Bosker WM, Huestis MA. Oral fluid testing for drugs of abuse. Clin Chem. 2009 Nov; 55(11):1910-31. PMID: 19745062.
      Citations:    
    385. Shakleya DM, Huestis MA. Simultaneous and sensitive measurement of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Nov 01; 877(29):3537-42. PMID: 19748838.
      Citations:    
    386. Baumann MH, Zolkowska D, Kim I, Scheidweiler KB, Rothman RB, Huestis MA. Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat. Drug Metab Dispos. 2009 Nov; 37(11):2163-70. PMID: 19679675.
      Citations:    
    387. de Castro A, Concheiro M, Shakleya DM, Huestis MA. Development and validation of a liquid chromatography mass spectrometry assay for the simultaneous quantification of methadone, cocaine, opiates and metabolites in human umbilical cord. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Oct 01; 877(27):3065-71. PMID: 19656745.
      Citations:    
    388. Lowe RH, Abraham TT, Darwin WD, Herning R, Cadet JL, Huestis MA. Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure. Drug Alcohol Depend. 2009 Nov 01; 105(1-2):24-32. PMID: 19631478.
      Citations:    
    389. Della Grotta S, LaGasse LL, Arria AM, Derauf C, Grant P, Smith LM, Shah R, Huestis M, Liu J, Lester BM. Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Matern Child Health J. 2010 Jul; 14(4):519-27. PMID: 19565330.
      Citations:    
    390. Mueller M, Kolbrich EA, Peters FT, Maurer HH, McCann UD, Huestis MA, Ricaurte GA. Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans. Ther Drug Monit. 2009 Jun; 31(3):367-73. PMID: 19417716.
      Citations:    
    391. de Castro A, Concheiro M, Shakleya DM, Huestis MA. Simultaneous quantification of methadone, cocaine, opiates, and metabolites in human placenta by liquid chromatography-mass spectrometry. J Anal Toxicol. 2009 Jun; 33(5):243-52. PMID: 19671243.
      Citations:    
    392. Smith ML, Barnes AJ, Huestis MA. Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections. J Anal Toxicol. 2009 May; 33(4):185-9. PMID: 19470219.
      Citations:    
    393. Concheiro M, Shakleya DM, Huestis MA. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry. Forensic Sci Int. 2009 Jul 01; 188(1-3):144-51. PMID: 19406593.
      Citations:    
    394. Kacinko SL, Jones HE, Johnson RE, Choo RE, Concheiro-Guisan M, Huestis MA. Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment. Clin Chem. 2009 Jun; 55(6):1177-87. PMID: 19325013.
      Citations:    
    395. Schwilke EW, Karschner EL, Lowe RH, Gordon AM, Cadet JL, Herning RI, Huestis MA. Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing. Clin Chem. 2009 Jun; 55(6):1188-95. PMID: 19264857.
      Citations:    
    396. Concheiro-Guisan M, Shakleya DM, Huestis MA. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry. Anal Bioanal Chem. 2009 May; 394(2):513-22. PMID: 19247639.
      Citations:    
    397. Gray TR, Shakleya DM, Huestis MA. A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium. Anal Bioanal Chem. 2009 Apr; 393(8):1977-90. PMID: 19241063.
      Citations:    
    398. Shakleya DM, Huestis MA. Simultaneous quantification of nicotine, opioids, cocaine, and metabolites in human fetal postmortem brain by liquid chromatography tandem mass spectrometry. Anal Bioanal Chem. 2009 Apr; 393(8):1957-65. PMID: 19229524.
      Citations:    
    399. Gray TR, Kelly T, LaGasse LL, Smith LM, Derauf C, Haning W, Grant P, Shah R, Arria A, Strauss A, Lester BM, Huestis MA. Novel biomarkers of prenatal methamphetamine exposure in human meconium. Ther Drug Monit. 2009 Feb; 31(1):70-5. PMID: 19125148.
      Citations:    
    400. Mueller M, Kolbrich-Spargo EA, Peters FT, Huestis MA, Ricaurte GA, Maurer HH. Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma. Anal Bioanal Chem. 2009 Mar; 393(6-7):1607-17. PMID: 19183967.
      Citations:    
    401. Barnes AJ, De Martinis BS, Gorelick DA, Goodwin RS, Kolbrich EA, Huestis MA. Disposition of MDMA and metabolites in human sweat following controlled MDMA administration. Clin Chem. 2009 Mar; 55(3):454-62. PMID: 19168553.
      Citations:    
    402. Mueller M, Peters FT, Huestis MA, Ricaurte GA, Maurer HH. Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methylenedioxyamphetamine in squirrel monkey and human plasma after acidic conjugate cleavage. Forensic Sci Int. 2009 Jan 30; 184(1-3):64-8. PMID: 19131196.
      Citations:    
    403. Hahn B, Ross TJ, Wolkenberg FA, Shakleya DM, Huestis MA, Stein EA. Performance effects of nicotine during selective attention, divided attention, and simple stimulus detection: an fMRI study. Cereb Cortex. 2009 Sep; 19(9):1990-2000. PMID: 19073624.
      Citations:    
    404. Paz MS, Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Liu J, Lester BM. Maternal depression and neurobehavior in newborns prenatally exposed to methamphetamine. Neurotoxicol Teratol. 2009 May-Jun; 31(3):177-82. PMID: 19059478.
      Citations:    
    405. Scheidweiler KB, Barnes AJ, Huestis MA. A validated gas chromatographic-electron impact ionization mass spectrometric method for methamphetamine, methylenedioxymethamphetamine (MDMA), and metabolites in mouse plasma and brain. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Dec 15; 876(2):266-76. PMID: 19026602.
      Citations:    
    406. Gray TR, Magri R, Shakleya DM, Huestis MA. Meconium nicotine and metabolites by liquid chromatography-tandem mass spectrometry: differentiation of passive and nonexposure and correlation with neonatal outcome measures. Clin Chem. 2008 Dec; 54(12):2018-27. PMID: 18845770.
      Citations:    
    407. Goodwin RS, Darwin WD, Chiang CN, Shih M, Li SH, Huestis MA. Urinary elimination of 11-nor-9-carboxy-delta9-tetrahydrocannnabinol in cannabis users during continuously monitored abstinence. J Anal Toxicol. 2008 Oct; 32(8):562-9. PMID: 19007504.
      Citations:    
    408. Kacinko SL, Concheiro-Guisan M, Shakleya DM, Huestis MA. Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of buprenorphine, norbuprenorphine, and metabolites in human urine. Anal Bioanal Chem. 2008 Nov; 392(5):903-11. PMID: 18758763.
      Citations:    
    409. Kacinko SL, Jones HE, Johnson RE, Choo RE, Huestis MA. Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes. Clin Pharmacol Ther. 2008 Nov; 84(5):604-12. PMID: 18701886.
      Citations:    
    410. Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, Huestis MA. Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration. J Clin Psychopharmacol. 2008 Aug; 28(4):432-40. PMID: 18626271.
      Citations:    
    411. Walsh JM, Verstraete AG, Huestis MA, M?rland J. Guidelines for research on drugged driving. Addiction. 2008 Aug; 103(8):1258-68. PMID: 18855814.
      Citations:    
    412. Brunet BR, Barnes AJ, Scheidweiler KB, Mura P, Huestis MA. Development and validation of a solid-phase extraction gas chromatography-mass spectrometry method for the simultaneous quantification of methadone, heroin, cocaine and metabolites in sweat. Anal Bioanal Chem. 2008 Sep; 392(1-2):115-27. PMID: 18607576.
      Citations:    
    413. Lee CT, Chen J, Hayashi T, Tsai SY, Sanchez JF, Errico SL, Amable R, Su TP, Lowe RH, Huestis MA, Shen J, Becker KG, Geller HM, Freed WJ. A mechanism for the inhibition of neural progenitor cell proliferation by cocaine. PLoS Med. 2008 Jun 10; 5(6):e117. PMID: 18593214.
      Citations:    
    414. Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, Huestis MA. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Ther Drug Monit. 2008 Jun; 30(3):320-32. PMID: 18520604.
      Citations:    
    415. Kelly T, Gray TR, Huestis MA. Development and validation of a liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for simultaneous analysis of 10 amphetamine-, methamphetamine- and 3,4-methylenedioxymethamphetamine-related (MDMA) analytes in human meconium. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 May 15; 867(2):194-204. PMID: 18424195.
      Citations:    
    416. Jansson LM, Choo R, Velez ML, Lowe R, Huestis MA. Methadone maintenance and long-term lactation. Breastfeed Med. 2008 Mar; 3(1):34-7. PMID: 18333767.
      Citations:    
    417. Gray TR, Shakleya DM, Huestis MA. Quantification of nicotine, cotinine, trans-3'-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Feb 15; 863(1):107-14. PMID: 18243821.
      Citations:    
    418. Lehrmann E, Afanador ZR, Deep-Soboslay A, Gallegos G, Darwin WD, Lowe RH, Barnes AJ, Huestis MA, Cadet JL, Herman MM, Hyde TM, Kleinman JE, Freed WJ. Postmortem diagnosis and toxicological validation of illicit substance use. Addict Biol. 2008 Mar; 13(1):105-17. PMID: 18201295.
      Citations:    
    419. Elkashef A, Vocci F, Huestis M, Haney M, Budney A, Gruber A, el-Guebaly N. Marijuana neurobiology and treatment. Subst Abus. 2008; 29(3):17-29. PMID: 19042204.
      Citations:    
    420. Jansson LM, Choo R, Velez ML, Harrow C, Schroeder JR, Shakleya DM, Huestis MA. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics. 2008 Jan; 121(1):106-14. PMID: 18166563.
      Citations:    
    421. Kanneganti P, Huestis MA, Kolbrich EA, Goodwin R, Ziegelstein RC, Gorelick DA. Signal-averaged electrocardiogram in physically healthy, chronic 3,4-methylenedioxymethamphetamine (MDMA) users. Am J Drug Alcohol Abuse. 2008; 34(6):712-20. PMID: 18855243.
      Citations:    
    422. Kolbrich EA, Lowe RH, Huestis MA. Two-dimensional gas chromatography/electron-impact mass spectrometry with cryofocusing for simultaneous quantification of MDMA, MDA, HMMA, HMA, and MDEA in human plasma. Clin Chem. 2008 Feb; 54(2):379-87. PMID: 18089653.
      Citations:    
    423. Kacinko SL, Shakleya DM, Huestis MA. Validation and application of a method for the determination of buprenorphine, norbuprenorphine, and their glucuronide conjugates in human meconium. Anal Chem. 2008 Jan 01; 80(1):246-52. PMID: 18044957.
      Citations:    
    424. Barnes AJ, Smith ML, Kacinko SL, Schwilke EW, Cone EJ, Moolchan ET, Huestis MA. Excretion of methamphetamine and amphetamine in human sweat following controlled oral methamphetamine administration. Clin Chem. 2008 Jan; 54(1):172-80. PMID: 17981924.
      Citations:    
    425. Goodwin RS, Wilkins DG, Averin O, Choo RE, Schroeder JR, Jasinski DR, Johnson RE, Jones HE, Huestis MA. Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration. Clin Chem. 2007 Dec; 53(12):2136-43. PMID: 17921260.
      Citations:    
    426. Smith LM, Lagasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Fallone M, Liu J, Lester BM. Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol. 2008 Jan-Feb; 30(1):20-8. PMID: 18031987.
      Citations:    
    427. Abraham TT, Lowe RH, Pirnay SO, Darwin WD, Huestis MA. Simultaneous GC-EI-MS determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis. J Anal Toxicol. 2007 Oct; 31(8):477-85. PMID: 17988462.
      Citations:    
    428. Huestis MA, Darwin WD, Shimomura E, Lalani SA, Trinidad DV, Jenkins AJ, Cone EJ, Jacobs AJ, Smith ML, Paul BD. Cocaine and metabolites urinary excretion after controlled smoked administration. J Anal Toxicol. 2007 Oct; 31(8):462-8. PMID: 17988460.
      Citations:    
    429. Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers. 2007 Aug; 4(8):1770-804. PMID: 17712819.
      Citations:    
    430. Huestis MA, Boyd SJ, Heishman SJ, Preston KL, Bonnet D, Le Fur G, Gorelick DA. Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology (Berl). 2007 Nov; 194(4):505-15. PMID: 17619859.
      Citations:    
    431. Lowe RH, Karschner EL, Schwilke EW, Barnes AJ, Huestis MA. Simultaneous quantification of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. J Chromatogr A. 2007 Sep 07; 1163(1-2):318-27. PMID: 17640656.
      Citations:    
    432. Shakleya DM, Jansson LM, Huestis MA. Validation of a LC-APCI-MS/MS method for quantification of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) and 2-ethyl-5-methyl-3,3-diphenylpyraline (EMDP) in infant plasma following protein precipitation. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Sep 01; 856(1-2):267-72. PMID: 17602899.
      Citations:    
    433. Smith ML, Vorce SP, Holler JM, Shimomura E, Magluilo J, Jacobs AJ, Huestis MA. Modern instrumental methods in forensic toxicology. J Anal Toxicol. 2007 Jun; 31(5):237-53, 8A-9A. PMID: 17579968.
      Citations:    
    434. Choo RE, Jansson LM, Scheidweiler K, Huestis MA. A validated liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometric method for the quantification of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), and 2-Ethyl-5-methyl-3,3-diphenylpyroline (EMDP) in human breast milk. J Anal Toxicol. 2007 Jun; 31(5):265-9. PMID: 17579970.
      Citations:    
    435. Huestis MA, Scheidweiler KB, Saito T, Fortner N, Abraham T, Gustafson RA, Smith ML. Excretion of Delta9-tetrahydrocannabinol in sweat. Forensic Sci Int. 2008 Jan 30; 174(2-3):173-7. PMID: 17481836.
      Citations:    
    436. Jansson LM, Choo RE, Harrow C, Velez M, Schroeder JR, Lowe R, Huestis MA. Concentrations of methadone in breast milk and plasma in the immediate perinatal period. J Hum Lact. 2007 May; 23(2):184-90. PMID: 17478871.
      Citations:    
    437. Hahn B, Ross TJ, Yang Y, Kim I, Huestis MA, Stein EA. Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network. J Neurosci. 2007 Mar 28; 27(13):3477-89. PMID: 17392464.
      Citations:    
    438. Gray T, Huestis M. Bioanalytical procedures for monitoring in utero drug exposure. Anal Bioanal Chem. 2007 Aug; 388(7):1455-65. PMID: 17370066.
      Citations:    
    439. Cone EJ, Huestis MA. Interpretation of oral fluid tests for drugs of abuse. Ann N Y Acad Sci. 2007 Mar; 1098:51-103. PMID: 17332074.
      Citations:    
    440. Huestis MA, Cone EJ. Methamphetamine disposition in oral fluid, plasma, and urine. Ann N Y Acad Sci. 2007 Mar; 1098:104-21. PMID: 17332086.
      Citations:    
    441. De Martinis BS, Barnes AJ, Scheidweiler KB, Huestis MA. Development and validation of a disk solid phase extraction and gas chromatography-mass spectrometry method for MDMA, MDA, HMMA, HMA, MDEA, methamphetamine and amphetamine in sweat. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 01; 852(1-2):450-8. PMID: 17369000.
      Citations:    
    442. Derauf C, LaGasse LL, Smith LM, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Liu J, Lester BM. Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL). Am J Drug Alcohol Abuse. 2007; 33(2):281-9. PMID: 17497551.
      Citations:    
    443. Lehrmann E, Colantuoni C, Deep-Soboslay A, Becker KG, Lowe R, Huestis MA, Hyde TM, Kleinman JE, Freed WJ. Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse. PLoS One. 2006 Dec 27; 1:e114. PMID: 17205118.
      Citations:    
    444. Kolbrich EA, Barnes AJ, Gorelick DA, Boyd SJ, Cone EJ, Huestis MA. Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration. J Anal Toxicol. 2006 Oct; 30(8):501-10. PMID: 17132243.
      Citations:    
    445. Pirnay SO, Abraham TT, Lowe RH, Huestis MA. Selection and optimization of hydrolysis conditions for the quantification of urinary metabolites of MDMA. J Anal Toxicol. 2006 Oct; 30(8):563-9. PMID: 17132253.
      Citations:    
    446. Dams R, Choo RE, Lambert WE, Jones H, Huestis MA. Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients. Drug Alcohol Depend. 2007 Mar 16; 87(2-3):258-67. PMID: 17008030.
      Citations:    
    447. Huestis MA, Gustafson RA, Moolchan ET, Barnes A, Bourland JA, Sweeney SA, Hayes EF, Carpenter PM, Smith ML. Cannabinoid concentrations in hair from documented cannabis users. Forensic Sci Int. 2007 Jul 04; 169(2-3):129-36. PMID: 16963215.
      Citations:    
    448. Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Liu J, Lester BM. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics. 2006 Sep; 118(3):1149-56. PMID: 16951010.
      Citations:    
    449. Goodwin RS, Gustafson RA, Barnes A, Nebro W, Moolchan ET, Huestis MA. Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids. Ther Drug Monit. 2006 Aug; 28(4):545-51. PMID: 16885723.
      Citations:    
    450. Huestis MA, Elsohly M, Nebro W, Barnes A, Gustafson RA, Smith ML. Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations. Ther Drug Monit. 2006 Aug; 28(4):540-4. PMID: 16885722.
      Citations:    
    451. Pirnay SO, Abraham TT, Huestis MA. Sensitive gas chromatography-mass spectrometry method for simultaneous measurement of MDEA, MDMA, and metabolites HMA, MDA, and HMMA in human urine. Clin Chem. 2006 Sep; 52(9):1728-34. PMID: 16858076.
      Citations:    
    452. Copersino ML, Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Quitting among non-treatment-seeking marijuana users: reasons and changes in other substance use. Am J Addict. 2006 Jul-Aug; 15(4):297-302. PMID: 16867925.
      Citations:    
    453. Kim I, Huestis MA. A validated method for the determination of nicotine, cotinine, trans-3'-hydroxycotinine, and norcotinine in human plasma using solid-phase extraction and liquid chromatography-atmospheric pressure chemical ionization-mass spectrometry. J Mass Spectrom. 2006 Jun; 41(6):815-21. PMID: 16705667.
      Citations:    
    454. Schwilke EW, Barnes AJ, Kacinko SL, Cone EJ, Moolchan ET, Huestis MA. Opioid disposition in human sweat after controlled oral codeine administration. Clin Chem. 2006 Aug; 52(8):1539-45. PMID: 16740647.
      Citations:    
    455. Scheidweiler KB, Huestis MA. A validated gas chromatographic-electron impact ionization mass spectrometric method for methylenedioxymethamphetamine (MDMA), methamphetamine and metabolites in oral fluid. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 May 01; 835(1-2):90-9. PMID: 16580268.
      Citations:    
    456. Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Huestis MA. The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers. Am Heart J. 2006 Mar; 151(3):754.e1-754.e5. PMID: 16504646.
      Citations:    
    457. Yang W, Barnes AJ, Ripple MG, Fowler DR, Cone EJ, Moolchan ET, Chung H, Huestis MA. Simultaneous quantification of methamphetamine, cocaine, codeine, and metabolites in skin by positive chemical ionization gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Apr 03; 833(2):210-8. PMID: 16500159.
      Citations:    
    458. Lowe RH, Barnes AJ, Lehrmann E, Freed WJ, Kleinman JE, Hyde TM, Herman MM, Huestis MA. A validated positive chemical ionization GC/MS method for the identification and quantification of amphetamine, opiates, cocaine, and metabolites in human postmortem brain. J Mass Spectrom. 2006 Feb; 41(2):175-84. PMID: 16382483.
      Citations:    
    459. Arria AM, Derauf C, Lagasse LL, Grant P, Shah R, Smith L, Haning W, Huestis M, Strauss A, Della Grotta S, Liu J, Lester B. Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study. Matern Child Health J. 2006 May; 10(3):293-302. PMID: 16395620.
      Citations:    
    460. Huestis MA, Smith ML. Modern analytical technologies for the detection of drug abuse and doping. Drug Discov Today Technol. 2006; 3(1):49-57. PMID: 24980101.
      Citations:    
    461. Copersino ML, Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Cannabis withdrawal among non-treatment-seeking adult cannabis users. Am J Addict. 2006 Jan-Feb; 15(1):8-14. PMID: 16449088.
      Citations:    
    462. Paul BD, Lalani S, Bosy T, Jacobs AJ, Huestis MA. Concentration profiles of cocaine, pyrolytic methyl ecgonidine and thirteen metabolites in human blood and urine: determination by gas chromatography-mass spectrometry. Biomed Chromatogr. 2005 Nov; 19(9):677-88. PMID: 15841503.
      Citations:    
    463. Murphy CM, Huestis MA. LC-ESI-MS/MS analysis for the quantification of morphine, codeine, morphine-3-beta-D-glucuronide, morphine-6-beta-D-glucuronide, and codeine-6-beta-D-glucuronide in human urine. J Mass Spectrom. 2005 Nov; 40(11):1412-6. PMID: 16258895.
      Citations:    
    464. Huestis MA, Barnes A, Smith ML. Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations. Clin Chem. 2005 Dec; 51(12):2289-95. PMID: 16223887.
      Citations:    
    465. Kim I, Wtsadik A, Choo RE, Jones HE, Huestis MA. Usefulness of salivary trans-3'-hydroxycotinine concentration and trans-3'-hydroxycotinine/cotinine ratio as biomarkers of cigarette smoke in pregnant women. J Anal Toxicol. 2005 Oct; 29(7):689-95. PMID: 16419402.
      Citations:    
    466. Kacinko SL, Barnes AJ, Schwilke EW, Cone EJ, Moolchan ET, Huestis MA. Disposition of cocaine and its metabolites in human sweat after controlled cocaine administration. Clin Chem. 2005 Nov; 51(11):2085-94. PMID: 16166169.
      Citations:    
    467. Jones HE, Johnson RE, Jasinski DR, O'Grady KE, Chisholm CA, Choo RE, Crocetti M, Dudas R, Harrow C, Huestis MA, Jansson LM, Lantz M, Lester BM, Milio L. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend. 2005 Jul; 79(1):1-10. PMID: 15943939.
      Citations:    
    468. Scheidweiler KB, Cone EJ, Moolchan ET, Huestis MA. Dose-related distribution of codeine, cocaine, and metabolites into human hair following controlled oral codeine and subcutaneous cocaine administration. J Pharmacol Exp Ther. 2005 May; 313(2):909-15. PMID: 15743923.
      Citations:    
    469. Choo RE, Murphy CM, Jones HE, Huestis MA. Determination of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, 2-ethyl-5-methyl-3,3-diphenylpyraline and methadol in meconium by liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jan 25; 814(2):369-73. PMID: 15639461.
      Citations:    
    470. Kim I, Darwin WD, Huestis MA. Simultaneous determination of nicotine, cotinine, norcotinine, and trans-3'-hydroxycotinine in human oral fluid using solid phase extraction and gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jan 25; 814(2):233-40. PMID: 15639444.
      Citations:    
    471. Murphy CM, Huestis MA. Liquid chromatographic/electrospray ionization tandem mass spectrometric analysis for the quantification of buprenorphine, norbuprenorphine, buprenorphine-3-beta-D-glucuronide and norbuprenorphine-3-beta-D-glucuronide in human plasma. J Mass Spectrom. 2005 Jan; 40(1):70-4. PMID: 15637731.
      Citations:    
    472. Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Strategies for quitting among non-treatment-seeking marijuana smokers. Am J Addict. 2005 Jan-Feb; 14(1):35-42. PMID: 15804875.
      Citations:    
    473. Moolchan ET, Zimmerman D, Sehnert SS, Zimmerman D, Huestis MA, Epstein DH. Recent marijuana blunt smoking impacts carbon monoxide as a measure of adolescent tobacco abstinence. Subst Use Misuse. 2005; 40(2):231-40. PMID: 15770886.
      Citations:    
    474. Huestis MA. Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol. Handb Exp Pharmacol. 2005; (168):657-90. PMID: 16596792.
      Citations:    
    475. Kim I, Oyler JM, Moolchan ET, Cone EJ, Huestis MA. Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans. Ther Drug Monit. 2004 Dec; 26(6):664-72. PMID: 15570192.
      Citations:    
    476. Umbricht A, Huestis MA, Cone EJ, Preston KL. Effects of high-dose intravenous buprenorphine in experienced opioid abusers. J Clin Psychopharmacol. 2004 Oct; 24(5):479-87. PMID: 15349002.
      Citations:    
    477. Choo RE, Huestis MA, Schroeder JR, Shin AS, Jones HE. Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend. 2004 Sep 06; 75(3):253-60. PMID: 15283946.
      Citations:    
    478. Huestis MA, Cone EJ. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J Anal Toxicol. 2004 Sep; 28(6):394-9. PMID: 15516285.
      Citations:    
    479. Scheidweiler KB, Huestis MA. Simultaneous quantification of opiates, cocaine, and metabolites in hair by LC-APCI-MS/MS. Anal Chem. 2004 Aug 01; 76(15):4358-63. PMID: 15283573.
      Citations:    
    480. Saito T, Wtsadik A, Scheidweiler KB, Fortner N, Takeichi S, Huestis MA. Validated gas chromatographic-negative ion chemical ionization mass spectrometric method for delta(9)-tetrahydrocannabinol in sweat patches. Clin Chem. 2004 Nov; 50(11):2083-90. PMID: 15271860.
      Citations:    
    481. Kacinko SL, Barnes AJ, Kim I, Moolchan ET, Wilson L, Cooper GA, Reid C, Baldwin D, Hand CW, Huestis MA. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration. Forensic Sci Int. 2004 Apr 20; 141(1):41-8. PMID: 15066713.
      Citations:    
    482. Gustafson RA, Kim I, Stout PR, Klette KL, George MP, Moolchan ET, Levine B, Huestis MA. Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration. J Anal Toxicol. 2004 Apr; 28(3):160-7. PMID: 15107145.
      Citations:    
    483. Choo RE, Huestis MA. Oral fluid as a diagnostic tool. Clin Chem Lab Med. 2004; 42(11):1273-87. PMID: 15576290.
      Citations:    
    484. Gustafson RA, Moolchan ET, Barnes A, Levine B, Huestis MA. Validated method for the simultaneous determination of Delta 9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in human plasma using solid phase extraction and gas chromatography-mass spectrometry with positive chemical ionization. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Dec 05; 798(1):145-54. PMID: 14630369.
      Citations:    
    485. Dams R, Huestis MA, Lambert WE, Murphy CM. Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid. J Am Soc Mass Spectrom. 2003 Nov; 14(11):1290-4. PMID: 14597119.
      Citations:    
    486. Kolbrich EA, Kim I, Barnes AJ, Moolchan ET, Wilson L, Cooper GA, Reid C, Baldwin D, Hand CW, Huestis MA. Cozart RapiScan Oral Fluid Drug Testing System: an evaluation of sensitivity, specificity, and efficiency for cocaine detection compared with ELISA and GC-MS following controlled cocaine administration. J Anal Toxicol. 2003 Oct; 27(7):407-11. PMID: 14606993.
      Citations:    
    487. Barnes AJ, Kim I, Schepers R, Moolchan ET, Wilson L, Cooper G, Reid C, Hand C, Huestis MA. Sensitivity, specificity, and efficiency in detecting opiates in oral fluid with the Cozart Opiate Microplate EIA and GC-MS following controlled codeine administration. J Anal Toxicol. 2003 Oct; 27(7):402-7. PMID: 14606992.
      Citations:    
    488. Cone EJ, Sampson-Cone AH, Darwin WD, Huestis MA, Oyler JM. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results. J Anal Toxicol. 2003 Oct; 27(7):386-401. PMID: 14606991.
      Citations:    
    489. Kim I, Barnes AJ, Schepers R, Moolchan ET, Wilson L, Cooper G, Reid C, Hand C, Huestis MA. Sensitivity and specificity of the Cozart microplate EIA cocaine oral fluid at proposed screening and confirmation cutoffs. Clin Chem. 2003 Sep; 49(9):1498-503. PMID: 12928231.
      Citations:    
    490. Preston KL, Epstein DH, Davoudzadeh D, Huestis MA. Methadone and metabolite urine concentrations in patients maintained on methadone. J Anal Toxicol. 2003 Sep; 27(6):332-41. PMID: 14516485.
      Citations:    
    491. Gustafson RA, Levine B, Stout PR, Klette KL, George MP, Moolchan ET, Huestis MA. Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans. Clin Chem. 2003 Jul; 49(7):1114-24. PMID: 12816908.
      Citations:    
    492. Pope HG, Gruber AJ, Hudson JI, Cohane G, Huestis MA, Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend. 2003 Apr 01; 69(3):303-10. PMID: 12633916.
      Citations:    
    493. Dams R, Murphy CM, Choo RE, Lambert WE, De Leenheer AP, Huestis MA. LC-atmospheric pressure chemical ionization-MS/ MS analysis of multiple illicit drugs, methadone, and their metabolites in oral fluid following protein precipitation. Anal Chem. 2003 Feb 15; 75(4):798-804. PMID: 12622369.
      Citations:    
    494. Schepers RJ, Oyler JM, Joseph RE, Cone EJ, Moolchan ET, Huestis MA. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem. 2003 Jan; 49(1):121-32. PMID: 12507968.
      Citations:    
    495. Dams R, Murphy CM, Lambert WE, Huestis MA. Urine drug testing for opioids, cocaine, and metabolites by direct injection liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2003; 17(14):1665-70. PMID: 12845594.
      Citations:    
    496. Lehrmann E, Oyler J, Vawter MP, Hyde TM, Kolachana B, Kleinman JE, Huestis MA, Becker KG, Freed WJ. Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse. Pharmacogenomics J. 2003; 3(1):27-40. PMID: 12629581.
      Citations:    
    497. Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Cognitive measures in long-term cannabis users. J Clin Pharmacol. 2002 11; 42(S1):41S-47S. PMID: 12412835.
      Citations:    
    498. Oyler JM, Cone EJ, Joseph RE, Moolchan ET, Huestis MA. Duration of detectable methamphetamine and amphetamine excretion in urine after controlled oral administration of methamphetamine to humans. Clin Chem. 2002 Oct; 48(10):1703-14. PMID: 12324487.
      Citations:    
    499. Preston KL, Epstein DH, Cone EJ, Wtsadik AT, Huestis MA, Moolchan ET. Urinary elimination of cocaine metabolites in chronic cocaine users during cessation. J Anal Toxicol. 2002 Oct; 26(7):393-400. PMID: 12422991.
      Citations:    
    500. Kim I, Barnes AJ, Oyler JM, Schepers R, Joseph RE, Cone EJ, Lafko D, Moolchan ET, Huestis MA. Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration. Clin Chem. 2002 Sep; 48(9):1486-96. PMID: 12194925.
      Citations:    
    501. LeBeau MA, Christenson RH, Levine B, Darwin WD, Huestis MA. Intra- and interindividual variations in urinary concentrations of endogenous gamma-hydroxybutyrate. J Anal Toxicol. 2002 Sep; 26(6):340-6. PMID: 12220015.
      Citations:    
    502. Huestis MA, Choo RE. Drug abuse's smallest victims: in utero drug exposure. Forensic Sci Int. 2002 Aug 14; 128(1-2):20-30. PMID: 12208017.
      Citations:    
    503. Huestis MA. Cannabis (Marijuana) - Effects on Human Performance and Behavior. Forensic Sci Rev. 2002 Feb; 14(1-2):15-60. PMID: 26256486.
      Citations:    
    504. Steckley SL, Darwin WD, Henningfield JE, Huestis MA, Pickworth WB. Eclipse can deliver crack cocaine. Nicotine Tob Res. 2002; 4 Suppl 2:S189-90. PMID: 12573180.
      Citations:    
    505. Spanbauer AC, Casseday S, Davoudzadeh D, Preston KL, Huestis MA. Detection of opiate use in a methadone maintenance treatment population with the CEDIA 6-acetylmorphine and CEDIA DAU opiate assays. J Anal Toxicol. 2001 Oct; 25(7):515-9. PMID: 11599593.
      Citations:    
    506. Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry. 2001 Oct; 58(10):909-15. PMID: 11576028.
      Citations:    
    507. Huang W, Moody DE, Andrenyak DM, Smith EK, Foltz RL, Huestis MA, Newton JF. Simultaneous determination of delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol in human plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry. J Anal Toxicol. 2001 Oct; 25(7):531-7. PMID: 11599596.
      Citations:    
    508. Lyons TP, Okano CK, Kuhnle JA, Bruins MR, Darwin WD, Moolchan ET, Huestis MA. A comparison of Roche Kinetic Interaction of Microparticles in Solution (KIMS) assay for cannabinoids and GC-MS analysis for 11-nor-9-carboxy-delta9-tetrahydrocannabinol. J Anal Toxicol. 2001 Oct; 25(7):559-64. PMID: 11599600.
      Citations:    
    509. Polettini A, Huestis MA. Simultaneous determination of buprenorphine, norbuprenorphine, and buprenorphine-glucuronide in plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl. 2001 Apr 25; 754(2):447-59. PMID: 11339288.
      Citations:    
    510. Huestis MA, Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Frank RA. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry. 2001 Apr; 58(4):322-8. PMID: 11296091.
      Citations:    
    511. Lester BM, ElSohly M, Wright LL, Smeriglio VL, Verter J, Bauer CR, Shankaran S, Bada HS, Walls HH, Huestis MA, Finnegan LP, Maza PL. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics. 2001 Feb; 107(2):309-17. PMID: 11158464.
      Citations:    
    512. Woods AS, Huestis MA. A study of peptide--peptide interaction by matrix-assisted laser desorption/ionization. J Am Soc Mass Spectrom. 2001 Jan; 12(1):88-96. PMID: 11142364.
      Citations:    
    513. Krasnova IN, Ladenheim B, Jayanthi S, Oyler J, Moran TH, Huestis MA, Cadet JL. Amphetamine-induced toxicity in dopamine terminals in CD-1 and C57BL/6J mice: complex roles for oxygen-based species and temperature regulation. Neuroscience. 2001; 107(2):265-74. PMID: 11731100.
      Citations:    
    514. Ladenheim B, Krasnova IN, Deng X, Oyler JM, Polettini A, Moran TH, Huestis MA, Cadet JL. Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6. Mol Pharmacol. 2000 Dec; 58(6):1247-56. PMID: 11093760.
      Citations:    
    515. Moolchan ET, Cone EJ, Wstadik A, Huestis MA, Preston KL. Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: plasma and saliva analysis. J Anal Toxicol. 2000 Oct; 24(7):458-66. PMID: 11043647.
      Citations:    
    516. Huestis MA, Cone EJ, Wong CJ, Umbricht A, Preston KL. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing. J Anal Toxicol. 2000 Oct; 24(7):509-21. PMID: 11043653.
      Citations:    
    517. Oyler JM, Cone EJ, Joseph RE, Huestis MA. Identification of hydrocodone in human urine following controlled codeine administration. J Anal Toxicol. 2000 Oct; 24(7):530-5. PMID: 11043655.
      Citations:    
    518. Huestis MA, Oyler JM, Cone EJ, Wstadik AT, Schoendorfer D, Joseph RE. Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl. 1999 Oct 15; 733(1-2):247-64. PMID: 10572984.
      Citations:    
    519. Nath N, Eldefrawi M, Wright J, Darwin D, Huestis M. A rapid reusable fiber optic biosensor for detecting cocaine metabolites in urine. J Anal Toxicol. 1999 Oct; 23(6):460-7. PMID: 10517551.
      Citations:    
    520. Preston KL, Huestis MA, Wong CJ, Umbricht A, Goldberger BA, Cone EJ. Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testing. J Anal Toxicol. 1999 Sep; 23(5):313-22. PMID: 10488917.
      Citations:    
    521. Huestis MA, Cone EJ. Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans. Ther Drug Monit. 1998 Oct; 20(5):570-6. PMID: 9780137.
      Citations:    
    522. Huestis MA, Cone EJ. Differentiating new marijuana use from residual drug excretion in occasional marijuana users. J Anal Toxicol. 1998 Oct; 22(6):445-54. PMID: 9788519.
      Citations:    
    523. Goldberger BA, Huestis MA, Wilkins DG. Commonly Practiced Quality Control and Quality Assurance Procedures for Gas Chromatography-Mass Spectrometry Analysis in Forensic Urine Drug-Testing Laboratories. Forensic Sci Rev. 1997 Dec; 9(2):59-80. PMID: 26269941.
      Citations:    
    524. Huestis MA, Mitchell JM, Cone EJ. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana. J Anal Toxicol. 1996 Oct; 20(6):441-52. PMID: 8889681.
      Citations:    
    525. Huestis MA. Judicial acceptance of hair tests for substances of abuse in the United States courts: scientific, forensic, and ethical aspects. Ther Drug Monit. 1996 Aug; 18(4):456-9. PMID: 8857568.
      Citations:    
    526. Wilkins D, Haughey H, Cone E, Huestis M, Foltz R, Rollins D. Quantitative analysis of THC, 11-OH-THC, and THCCOOH in human hair by negative ion chemical ionization mass spectrometry. J Anal Toxicol. 1995 Oct; 19(6):483-91. PMID: 8926743.
      Citations:    
    527. Huestis MA, Mitchell JM, Cone EJ. Detection times of marijuana metabolites in urine by immunoassay and GC-MS. J Anal Toxicol. 1995 Oct; 19(6):443-9. PMID: 8926739.
      Citations:    
    528. Jenkins AJ, Darwin WD, Huestis MA, Cone EJ, Mitchell JM. Validity testing of the accuPINCH THC test. J Anal Toxicol. 1995 Jan-Feb; 19(1):5-12. PMID: 7723303.
      Citations:    
    529. Huestis MA, Mitchell JM, Cone EJ. Lowering the federally mandated cannabinoid immunoassay cutoff increases true-positive results. Clin Chem. 1994 May; 40(5):729-33. PMID: 8174244.
      Citations:    
    530. Cone EJ, Huestis MA. Relating blood concentrations of tetrahydrocannabinol and metabolites to pharmacologic effects and time of marijuana usage. Ther Drug Monit. 1993 Dec; 15(6):527-32. PMID: 8122288.
      Citations:    
    531. Jenkins AJ, Mills LC, Darwin WD, Huestis MA, Cone EJ, Mitchell JM. Validity testing of the EZ-SCREEN cannabinoid test. J Anal Toxicol. 1993 Sep; 17(5):292-8. PMID: 8107464.
      Citations:    
    532. Cone EJ, Huestis MA, Mitchell JM. Do consecutive urine catches differ in marijuana metabolite concentration? J Anal Toxicol. 1993 May-Jun; 17(3):186-7. PMID: 8336494.
      Citations:    
    533. Huestis MA, Henningfield JE, Cone EJ. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol. 1992 Sep-Oct; 16(5):276-82. PMID: 1338215.
      Citations:    
    534. Huestis MA, Henningfield JE, Cone EJ. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH) J Anal Toxicol. 1992 Sep-Oct; 16(5):283-90. PMID: 1338216.
      Citations:    
    535. Huestis MA, Sampson AH, Holicky BJ, Henningfield JE, Cone EJ. Characterization of the absorption phase of marijuana smoking. Clin Pharmacol Ther. 1992 Jul; 52(1):31-41. PMID: 1320536.
      Citations:    
    536. Heishman SJ, Huestis MA, Henningfield JE, Cone EJ. Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures. Pharmacol Biochem Behav. 1990 Nov; 37(3):561-5. PMID: 1965045.
      Citations:    
    537. Cone EJ, Huestis MA. Urinary Excretion of Commonly Abused Drugs Following Uncommon Means of Administration. Forensic Sci Rev. 1989 Dec; 1(2):121-39. PMID: 26266580.
      Citations:    
    Huestis's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (789)
    Explore
    _
    Co-Authors (4)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _